Prompt = """
You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query to the search engine based on what you already know at each step of the reasoning chain, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
For example:
### User: [Question]: A 56-year-old man presents to the clinic complaining of subacute back pain for the past month. The pain is described as a dull, constant ache that is worse at night. He could not recall any precipitating event except for an amateur weight-lifting competition that he participated in 2 months ago. Past medical history is significant for non-small cell lung cancer that was diagnosed and successfully treated. A PET scan 1 year ago demonstrated no recurrence. Physical exam was unremarkable except for some point tenderness along the lumbosacral area. What is the most likely imaging finding in this patient?, "A": "Blastic lesions of the lumbar spine", "B": "Bulging disc impinging on lumbar spinal nerve", "C": "Lytic lesions of the lumbar spine", "D": "Narrowing of the lumbar disc space", "E": "Sacroilitis and fusion of the lumbar spine"
### Assistant: [Query 1]: What are the typical causes of back pain in patients with a history of cancer, especially when pain is worse at night?
[Answer 1]: In patients with a history of cancer, particularly lung cancer, back pain that worsens at night raises concern for metastatic disease to the bone, as metastatic lesions often cause constant, night-predominant pain.
[Query 2]: What types of bone lesions are most commonly associated with lung cancer metastasis?
[Answer 2]: Lung cancer frequently causes lytic bone lesions, characterized by bone destruction, which can lead to pain and structural weakness at the site of metastasis.
[Query 3]: What are lytic lesions, and why do they cause localized tenderness?
[Answer 3]: Lytic lesions are areas of bone loss or destruction due to metastatic invasion by cancer cells. These lesions weaken the bone structure, often resulting in localized pain and tenderness due to microfractures or increased bone instability.
[Query 4]: Why is a previous history of non-small cell lung cancer significant in this patient with subacute back pain?
[Answer 4]: Non-small cell lung cancer is known for its potential to recur and metastasize to the bones, even after a period of apparent remission, so new back pain in this context is suspicious for metastasis.
[Final Content]: [1] In patients with a history of cancer, particularly lung cancer, back pain that worsens at night raises concern for metastatic disease to the bone, as metastatic lesions often cause constant, night-predominant pain.
[2] Lung cancer frequently causes lytic bone lesions, characterized by bone destruction, which can lead to pain and structural weakness at the site of metastasis.
[3] Lytic lesions are areas of bone loss or destruction due to metastatic invasion by cancer cells. These lesions weaken the bone structure, often resulting in localized pain and tenderness due to microfractures or increased bone instability.
[4] Non-small cell lung cancer is known for its potential to recur and metastasize to the bones, even after a period of apparent remission, so new back pain in this context is suspicious for metastasis.
[5] The combination of prior lung cancer, dull back pain worse at night, and point tenderness on exam is consistent with lytic lesions of the lumbar spine, indicative of possible metastatic recurrence.
So the final answer is C: Lytic lesions of the lumbar spine.

### User: A 33-year-old nurse is referred to an infectious disease specialist after she exhibited a PPD skin test with 17 mm of induration. She denies any cough, shortness of breath, hemoptysis, weight loss, fatigue, fevers, or night sweats over the last several months. Her temperature is 97.0°F (36.1°C), blood pressure is 120/81 mmHg, pulse is 82/min, respirations are 15/min, and oxygen saturation is 98% on room air. An initial chest radiograph is unremarkable. Which of the following is the most appropriate management of this patient?
### Assistant: [Query 1] What does a PPD skin test induration of 17 mm indicate?
[Answer 1] A PPD skin test induration of 17 mm is considered a positive result for tuberculosis (TB) infection, particularly in individuals with no known risk factors for TB, as a cutoff of 15 mm is generally used for the general population.
[Query 2] What are the clinical implications of a positive PPD test in a patient without symptoms of active TB?
[Answer 2] A positive PPD test indicates latent TB infection (LTBI) in the absence of clinical symptoms and an unremarkable chest radiograph. Latent TB is not contagious and requires evaluation for treatment to prevent progression to active TB disease.
[Query 3] What is the standard management approach for latent TB infection?
[Answer 3] The standard management for latent TB infection is to initiate treatment with isoniazid for 6 to 9 months, which helps reduce the risk of developing active TB in the future.
[Query 4] Given the positive PPD test and absence of active TB symptoms, what would be the most appropriate choice from the management options provided?
[Answer 4] The most appropriate management for this patient, given the positive PPD test and absence of active TB symptoms, is to initiate treatment with isoniazid (Option A).
[Final Content]: [1] A PPD skin test induration of 17 mm is considered a positive result for tuberculosis (TB) infection, particularly in individuals with no known risk factors for TB, as a cutoff of 15 mm is generally used for the general population.
[2] A positive PPD test indicates latent TB infection (LTBI) in the absence of clinical symptoms and an unremarkable chest radiograph. Latent TB is not contagious and requires evaluation for treatment to prevent progression to active TB disease.
[3] The standard management for latent TB infection is to initiate treatment with isoniazid for 6 to 9 months, which helps reduce the risk of developing active TB in the future.
[4] The most appropriate management for this patient, given the positive PPD test and absence of active TB symptoms, is to initiate treatment with isoniazid (Option A).
So the final answer is A: Isoniazid.

You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query to the search engine based on what you already know at each step of the reasoning chain, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer]."""

Prompt_train = """
You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query to the search engine based on what you already know at each step of the reasoning chain, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer]."""

Prompt_inference = """
You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query to the search engine based on what you already know at each step of the reasoning chain, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer]."""


Prompt_gpt = """
You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query to the search engine based on what you already know at each step of the reasoning chain, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
For example:
User: [Question]: A 56-year-old man presents to the clinic complaining of subacute back pain for the past month. The pain is described as a dull, constant ache that is worse at night. He could not recall any precipitating event except for an amateur weight-lifting competition that he participated in 2 months ago. Past medical history is significant for non-small cell lung cancer that was diagnosed and successfully treated. A PET scan 1 year ago demonstrated no recurrence. Physical exam was unremarkable except for some point tenderness along the lumbosacral area. What is the most likely imaging finding in this patient?, "A": "Blastic lesions of the lumbar spine", "B": "Bulging disc impinging on lumbar spinal nerve", "C": "Lytic lesions of the lumbar spine", "D": "Narrowing of the lumbar disc space", "E": "Sacroilitis and fusion of the lumbar spine"
Assistant: [Query 1]: What are the typical causes of back pain in patients with a history of cancer, especially when pain is worse at night?
[Answer 1]: In patients with a history of cancer, particularly lung cancer, back pain that worsens at night raises concern for metastatic disease to the bone, as metastatic lesions often cause constant, night-predominant pain.
[Query 2]: What types of bone lesions are most commonly associated with lung cancer metastasis?
[Answer 2]: Lung cancer frequently causes lytic bone lesions, characterized by bone destruction, which can lead to pain and structural weakness at the site of metastasis.
[Query 3]: What are lytic lesions, and why do they cause localized tenderness?
[Answer 3]: Lytic lesions are areas of bone loss or destruction due to metastatic invasion by cancer cells. These lesions weaken the bone structure, often resulting in localized pain and tenderness due to microfractures or increased bone instability.
[Query 4]: Why is a previous history of non-small cell lung cancer significant in this patient with subacute back pain?
[Answer 4]: Non-small cell lung cancer is known for its potential to recur and metastasize to the bones, even after a period of apparent remission, so new back pain in this context is suspicious for metastasis.
[Final Content]: [1] In patients with a history of cancer, particularly lung cancer, back pain that worsens at night raises concern for metastatic disease to the bone, as metastatic lesions often cause constant, night-predominant pain.
[2] Lung cancer frequently causes lytic bone lesions, characterized by bone destruction, which can lead to pain and structural weakness at the site of metastasis.
[3] Lytic lesions are areas of bone loss or destruction due to metastatic invasion by cancer cells. These lesions weaken the bone structure, often resulting in localized pain and tenderness due to microfractures or increased bone instability.
[4] Non-small cell lung cancer is known for its potential to recur and metastasize to the bones, even after a period of apparent remission, so new back pain in this context is suspicious for metastasis.
[5] The combination of prior lung cancer, dull back pain worse at night, and point tenderness on exam is consistent with lytic lesions of the lumbar spine, indicative of possible metastatic recurrence.
So the final answer is C: Lytic lesions of the lumbar spine.

User: A 33-year-old nurse is referred to an infectious disease specialist after she exhibited a PPD skin test with 17 mm of induration. She denies any cough, shortness of breath, hemoptysis, weight loss, fatigue, fevers, or night sweats over the last several months. Her temperature is 97.0°F (36.1°C), blood pressure is 120/81 mmHg, pulse is 82/min, respirations are 15/min, and oxygen saturation is 98% on room air. An initial chest radiograph is unremarkable. Which of the following is the most appropriate management of this patient?
Assistant: [Query 1] What does a PPD skin test induration of 17 mm indicate?
[Answer 1] A PPD skin test induration of 17 mm is considered a positive result for tuberculosis (TB) infection, particularly in individuals with no known risk factors for TB, as a cutoff of 15 mm is generally used for the general population.
[Query 2] What are the clinical implications of a positive PPD test in a patient without symptoms of active TB?
[Answer 2] A positive PPD test indicates latent TB infection (LTBI) in the absence of clinical symptoms and an unremarkable chest radiograph. Latent TB is not contagious and requires evaluation for treatment to prevent progression to active TB disease.
[Query 3] What is the standard management approach for latent TB infection?
[Answer 3] The standard management for latent TB infection is to initiate treatment with isoniazid for 6 to 9 months, which helps reduce the risk of developing active TB in the future.
[Query 4] Given the positive PPD test and absence of active TB symptoms, what would be the most appropriate choice from the management options provided?
[Answer 4] The most appropriate management for this patient, given the positive PPD test and absence of active TB symptoms, is to initiate treatment with isoniazid (Option A).
[Final Content]: [1] A PPD skin test induration of 17 mm is considered a positive result for tuberculosis (TB) infection, particularly in individuals with no known risk factors for TB, as a cutoff of 15 mm is generally used for the general population.
[2] A positive PPD test indicates latent TB infection (LTBI) in the absence of clinical symptoms and an unremarkable chest radiograph. Latent TB is not contagious and requires evaluation for treatment to prevent progression to active TB disease.
[3] The standard management for latent TB infection is to initiate treatment with isoniazid for 6 to 9 months, which helps reduce the risk of developing active TB in the future.
[4] The most appropriate management for this patient, given the positive PPD test and absence of active TB symptoms, is to initiate treatment with isoniazid (Option A).
So the final answer is A: Isoniazid.

You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query to the search engine based on what you already know at each step of the reasoning chain, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer]."""



Prompt_gpt_ask_assistant = """
You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
In the node of the chain, you should query some relevant medical knowledge or play the role of a doctor and ask the patient about his or her symptoms, medical history, test results, etc. (even if they are already given in the case information).
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
For example:
User: [Question]: A 67-year-old man who was diagnosed with arthritis 16 years ago presents with right knee swelling and pain. His left knee was swollen a few weeks ago, but now with both joints affected, he has difficulty walking and feels frustrated. He also has back pain which makes it extremely difficult to move around and be active during the day. He says his pain significantly improves with rest. He also suffers from dandruff for which he uses special shampoos. Physical examination is notable for pitting of his nails. Which of the following is the most likely diagnosis? Options: "A": "Psoriatic arthritis", "B": "Arthritis mutilans", "C": "Rheumatoid arthritis", "D": "Familial mediterranean fever", "E": "Mixed connective tissue disease"
Assistant: [Query 1] Could you describe the patient's primary symptoms and the pattern of joint involvement?
[Answer 1] The patient has right knee swelling and pain, and he previously experienced left knee swelling. Both joints are now affected, causing difficulty in walking. There is also significant back pain that worsens with activity and improves with rest.
[Query 2] Is there a history of any skin or nail issues that might be relevant in this case?
[Answer 2] Yes, the patient has dandruff and uses special shampoos for it. Physical examination reveals nail pitting, which can be an indication of underlying skin conditions.
[Query 3] Does the patient have any additional symptoms or past medical history that could help in narrowing down the diagnosis?
[Answer 3] The patient has a 16-year history of arthritis but does not mention any other autoimmune or hereditary conditions. There are no indications of systemic symptoms such as fever or weight loss.
[Query 4] What conditions are characterized by arthritis, particularly with asymmetric joint involvement, back pain, and nail pitting?"
[Answer 4] Psoriatic arthritis is commonly associated with asymmetrical joint involvement, enthesitis, nail pitting, and can often coexist with psoriasis (manifested here as dandruff-like scalp involvement). Other possible conditions could include rheumatoid arthritis, which typically shows symmetrical involvement and lacks specific features like nail pitting, and arthritis mutilans, a severe form of psoriatic arthritis with joint deformity. Familial Mediterranean fever and mixed connective tissue disease are less likely due to the absence of systemic symptoms or features like rash, pleuritis, or fever.
[Final Content]: The patient has asymmetric joint involvement [1].
There are notable skin and nail findings (dandruff and nail pitting) that align with dermatologic manifestations often seen in psoriatic conditions [2].
The absence of systemic symptoms or symmetric involvement points away from conditions like rheumatoid arthritis or systemic connective tissue disorders [3].
Psoriatic arthritis, known for involving the skin, nails, and joints, as well as for back pain that improves with rest, matches the presentation closely [4].
So the final answer is A: Psoriatic arthritis.

User: [Question]: A 56-year-old man presents to the clinic complaining of subacute back pain for the past month. The pain is described as a dull, constant ache that is worse at night. He could not recall any precipitating event except for an amateur weight-lifting competition that he participated in 2 months ago. Past medical history is significant for non-small cell lung cancer that was diagnosed and successfully treated. A PET scan 1 year ago demonstrated no recurrence. Physical exam was unremarkable except for some point tenderness along the lumbosacral area. What is the most likely imaging finding in this patient?, "A": "Blastic lesions of the lumbar spine", "B": "Bulging disc impinging on lumbar spinal nerve", "C": "Lytic lesions of the lumbar spine", "D": "Narrowing of the lumbar disc space", "E": "Sacroilitis and fusion of the lumbar spine"
Assistant: [Query 1] Could you clarify the nature and location of the patient's back pain? Is it isolated to the lumbosacral region, or are other areas involved?
[Answer 1] The patient describes a dull, constant ache localized to the lumbosacral region, which worsens at night and has persisted for a month.
[Query 2] Does the patient report any associated neurological symptoms, such as radiating pain, numbness, or weakness in the lower extremities?
[Answer 2] No, the patient does not report any neurological symptoms. The pain is primarily localized without radiation or neurological deficits.
[Query 3] What is the patient’s past medical history, and are there any underlying conditions that could predispose him to certain spinal pathologies?
[Answer 3] The patient has a history of non-small cell lung cancer, which was treated successfully. A PET scan from a year ago showed no signs of recurrence.
[Query 4] Are there any risk factors or recent events that may contribute to the back pain?
[Answer 4] The patient participated in an amateur weight-lifting competition two months ago, which may have involved stress on the spine.
[Query 5] Considering the patient's cancer history and nocturnal pain, what imaging findings might be associated with recurrent cancer involving the spine?
[Answer 5] Recurrent malignancy, such as metastasis to the spine, is a concern, especially with symptoms like night pain. Non-small cell lung cancer commonly metastasizes to the bones, producing lytic lesions rather than blastic ones.
[Query 6] Could any other potential spinal pathologies account for back pain, especially nocturnal worsening, including degenerative changes or mechanical injury?
[Answer 6] Mechanical injuries, such as disc herniation, could cause back pain; however, such injuries more typically present with radiating pain or neurological symptoms. Degenerative disc narrowing could be considered, but the persistent, night-worsening pain aligns more closely with neoplastic processes.
[Final Content] The patient has subacute, persistent back pain isolated to the lumbosacral region with no neurological symptoms [1, 2].
His history of non-small cell lung cancer raises concerns for recurrence despite the negative PET scan a year ago [3].
Although there is a history of recent physical strain from weightlifting, the nature of the pain, especially nocturnal worsening, is concerning for malignancy rather than a mechanical or degenerative cause [4].
Lung cancer commonly metastasizes to the bones with a predilection for lytic lesions [5]. Therefore, the most likely imaging finding is C: Lytic lesions of the lumbar spine.
So the final answer is C: Lytic lesions of the lumbar spine.

User: [Question]: A 33-year-old nurse is referred to an infectious disease specialist after she exhibited a PPD skin test with 17 mm of induration. She denies any cough, shortness of breath, hemoptysis, weight loss, fatigue, fevers, or night sweats over the last several months. Her temperature is 97.0°F (36.1°C), blood pressure is 120/81 mmHg, pulse is 82/min, respirations are 15/min, and oxygen saturation is 98% on room air. An initial chest radiograph is unremarkable. Which of the following is the most appropriate management of this patient? Options: {"A": "Isoniazid", "B": "No management indicated", "C": "Quantiferon gold", "D": "Repeat PPD in 1 week", "E": "Rifampin, isoniazid, pyrazinamide, and ethambutol"}
Assistant: [Query 1] What does a PPD skin test induration of 17 mm indicate?
[Answer 1] A PPD skin test induration of 17 mm is considered a positive result for tuberculosis (TB) infection, particularly in individuals with no known risk factors for TB, as a cutoff of 15 mm is generally used for the general population.
[Query 2] What are the clinical implications of a positive PPD test in a patient without symptoms of active TB?
[Answer 2] A positive PPD test indicates latent TB infection (LTBI) in the absence of clinical symptoms and an unremarkable chest radiograph. Latent TB is not contagious and requires evaluation for treatment to prevent progression to active TB disease.
[Query 3] What is the standard management approach for latent TB infection?
[Answer 3] The standard management for latent TB infection is to initiate treatment with isoniazid for 6 to 9 months, which helps reduce the risk of developing active TB in the future.
[Query 4] Given the positive PPD test and absence of active TB symptoms, what would be the most appropriate choice from the management options provided?
[Answer 4] The most appropriate management for this patient, given the positive PPD test and absence of active TB symptoms, is to initiate treatment with isoniazid (Option A).
[Final Content]: A PPD skin test induration of 17 mm is considered a positive result for tuberculosis (TB) infection, particularly in individuals with no known risk factors for TB, as a cutoff of 15 mm is generally used for the general population [1].
A positive PPD test indicates latent TB infection (LTBI) in the absence of clinical symptoms and an unremarkable chest radiograph. Latent TB is not contagious and requires evaluation for treatment to prevent progression to active TB disease [2].
The standard management for latent TB infection is to initiate treatment with isoniazid for 6 to 9 months, which helps reduce the risk of developing active TB in the future [3].
The most appropriate management for this patient, given the positive PPD test and absence of active TB symptoms, is to initiate treatment with isoniazid (Option A) [4].
So the final answer is A: Isoniazid.

You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
In the node of the chain, you should query some relevant medical knowledge or play the role of a doctor and ask the patient about his or her symptoms, medical history, test results, etc. (even if they are already given in the case information).
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer]."""


Prompt_ask_assistant_train = """
You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
In the node of the chain, you should query some relevant medical knowledge or play the role of a doctor and ask the patient about his or her symptoms, medical history, test results, etc. (even if they are already given in the case information).
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer]."""

Prompt_ask_assistant_inference = """
You are an experienced medical professional. Based on the following patient case information, propose a possible diagnosis, ensuring that your diagnosis is reached through a step-by-step reasoning process.
Construct a global reasoning chain for the complex [Question]. For each node of the chain, you should generate a query, starting with [Query number].
You must give the answer for [Query number], starting with [Answer number].
In the node of the chain, you should query some relevant medical knowledge or play the role of a doctor and ask the patient about his or her symptoms, medical history, test results, etc. (even if they are already given in the case information).
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer]."""


Prompt_gpt_ask_assistant_v2 = """
You are an experienced medical professional. Your current role is a doctor who is examining a patient to answer the [Question]. The patient's description is in [Description of the patient].
You should pretend not to know the content in [symptoms, medical history, and test results] and get them through reasoning step by step in the chain to solve the [Question].
You should reason about the [Question] step by step and get content in [symptoms, medical history, and test results] during the reasoning process. Each question to access [symptoms, medical history, and test results] should arise naturally as part of the logical flow, ensuring that it aligns with the clinical reasoning process.
For each node of the chain, you should generate a query, starting with [Query number]. You must give the answer for [Query number], starting with [Answer number].
Each node of the chain can be a query and answer to the content in [symptoms, medical history, and test results], or a query and answer to related medical knowledge.
There should be strict logical connections between nodes, such as relevant medical knowledge or your medical experience
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
You must give the final answer by "So the final answer is ".
[Description of the patient]: 
[symptoms, medical history, and test results]: 
[Question]:

For example:
### User: [Description of the patient]: A 62-year-old woman is currently under regular medical supervision to address her heart health and related concerns. She experiences occasional episodes that affect her overall comfort and is actively participating in her treatment plan to enhance her quality of life and manage her heart condition effectively. 
[symptoms, medical history, and test results]:  \nSymptoms: Lightheadedness and palpitations occurring episodically.  \nMedical history: Myocardial infarction 6 months ago; NYHA class II chronic heart failure; diagnosed with grade I arterial hypertension 4 years ago.  \nMedications: Aspirin 81 mg, atorvastatin 10 mg, enalapril 10 mg, and metoprolol 200 mg daily.  \nVitals: Blood pressure 135/90 mm Hg; heart rate 125/min; respiratory rate 14/min; temperature 36.5\u00b0C (97.7\u00b0F).  \nCardiopulmonary examination: Irregular heart rhythm and decreased S1 intensity.  \nEchocardiography: Left ventricular ejection fraction of 39%.
[Question]: Which of the following drugs is the best choice for rate control in this patient? A: Atenolol B: Verapamil C: Diltiazem D: Propafenone E: Digoxin
### Assistant: [Query 1]: What are the patient's initial symptoms related to heart health?
[Answer 2]: The patient has had some lightheadedness and palpitations recently.
[Query 2]: What condition could explain the patient's symptoms of lightheadedness and palpitations?
[Answer 2]: Lightheadedness and palpitations could be caused by arrhythmias, such as atrial fibrillation (AF), or other cardiovascular issues like heart failure exacerbation or ischemia. Let’s confirm if the patient has signs of arrhythmia.
[Query 3]: What is the patient’s heart rate and rhythm?
[Answer 3]: The patient’s heart rate is 125 bpm, and her rhythm is irregular. This supports a diagnosis of atrial fibrillation (AF) causing rapid ventricular response. Rate control is a priority in managing this condition.
[Query 4]: Does the patient have underlying cardiac conditions that influence treatment decisions?
[Answer 4]: Yes, the patient has a history of myocardial infarction 6 months ago, NYHA class II chronic heart failure with reduced ejection fraction (HFrEF, EF 39%), and hypertension. These conditions impact the choice of medications for rate control.
[Query 5]: Are there contraindications to using certain rate control medications in this patient?
[Answer 5]: Non-dihydropyridine calcium channel blockers like verapamil and diltiazem are contraindicated in HFrEF due to their negative inotropic effects, which can worsen heart failure. Propafenone, a rhythm control drug, is also unsuitable due to proarrhythmic risks in structural heart disease.
[Query 6]: What medications is the patient currently taking, and do they address rate control?
[Answer 6]: The patient is on metoprolol 200 mg daily, which is a beta-blocker commonly used for rate control in AF and heart failure. However, her heart rate of 125 bpm suggests suboptimal rate control, indicating the need for an additional or alternative therapy.
[Query 7]: Why might digoxin be a good option in this patient?
[Answer 7]: Digoxin slows the ventricular rate in AF by enhancing vagal tone without adversely affecting cardiac output, making it particularly suitable for patients with HFrEF. It can be used as adjunctive therapy to improve rate control in this patient.
[Final Content]:
The patient has atrial fibrillation with rapid ventricular response (heart rate 125 bpm) [3].
She has underlying HFrEF and a history of myocardial infarction, influencing the choice of rate control medications [4].
Non-dihydropyridine calcium channel blockers and propafenone are contraindicated in this patient [5].
Atenolol is less effective in heart failure compared to her current beta-blocker (metoprolol) [6].
Digoxin is a safe and effective option for rate control in AF with HFrEF [7].
So the final answer is E: Digoxin.

### User: [Description of the patient]: A 46-year-old woman is currently undergoing treatment for a condition that has significantly affected her vision and overall well-being. She has been experiencing various symptoms that have emerged over the past few months, and she is in the process of working with her healthcare team to address these challenges while also managing some recent positive changes in her lifestyle
[symptoms, medical history, and test results]: Symptoms: 2-week history of diplopia; ocular pain when reading; 3-month history of amenorrhea, hot flashes, and increased sweating; fine resting tremor of the hands.  \nMedical history: Overweight all her adult life; lost 6.8-kg (15-lb) in the past 2 months.  \nVital signs: Pulse 110/min; blood pressure 148/98 mm Hg.  \nPhysical examination: Moist palms; nontender, enlarged thyroid gland; ophthalmologic findings of globe prominence, bilateral lid retraction, conjunctival injection, and inability to converge the eyes; pain-free extraocular muscle movement; visual acuity 20/20 bilaterally; deep tendon reflexes 3+ with shortened relaxation phase.
[Question]: Which of the following is the most likely cause of this patient's ocular complaints? A: Granulomatous inflammation of the cavernous sinus B: Abnormal communication between the cavernous sinus and the internal carotid artery C: Glycosaminoglycan accumulation in the orbit D: Bacterial infection of the orbital contents E: Sympathetic hyperactivity of levator palpebrae superioris
### Assistant: [Query 1]: What are the patient's initial symptoms related to her vision and well-being?
[Answer 1]: The patient reports a 2-week history of diplopia (double vision) and ocular pain when reading, along with other systemic symptoms like amenorrhea, hot flashes, and increased sweating.
[Query 2]: What could cause diplopia and ocular discomfort in this patient?
[Answer 2]: Diplopia and ocular discomfort can be caused by various conditions, including thyroid eye disease (Graves' ophthalmopathy), cranial nerve palsies, and other orbital pathologies. Given her systemic symptoms, it may be worth investigating if thyroid dysfunction is involved.
[Query 3]: Is there any evidence of thyroid dysfunction in the patient's clinical presentation?
[Answer 3]: Yes, the patient has an enlarged, nontender thyroid gland and associated symptoms indicating hyperthyroidism, such as increased sweating and weight loss, which is often seen in Graves’ disease.
[Query 4]: What specific findings in this patient suggest the diagnosis of Graves' disease?
[Answer 4]: The patient exhibits exophthalmos (globe prominence), bilateral lid retraction, and an inability to converge her eyes, all of which are indicative of thyroid-associated ophthalmopathy, commonly associated with Graves' disease.
[Query 5]: What role do glycosaminoglycans play in the ocular manifestations associated with Graves' disease?
[Answer 5]: Glycosaminoglycans, especially hyaluronic acid, accumulate in the orbit due to autoimmune processes in Graves’ disease, leading to edema and expansion of extraocular muscles, which can result in diplopia and other ocular symptoms.
[Query 6]: Given the findings, what is the most likely underlying cause of this patient's ocular complaints?
[Answer 6]: The ocular complaints primarily stem from the accumulation of glycosaminoglycans in the orbit as a result of Graves' disease, which affects the extraocular muscles and the surrounding tissues.
[Final Content]: 
The patient reports diplopia and ocular pain, signifying possible ocular pathology [1]. 
She has symptoms consistent with hyperthyroidism and Graves' disease, including globe prominence and other ocular signs [3]. 
Glycosaminoglycan accumulation typically occurs in the context of Graves' disease, leading to the associated ocular manifestations such as diplopia [5].
So the final answer is C: Glycosaminoglycan accumulation in the orbit."""


Prompt_gpt_ask_assistant_v2_with_mark = """
You are an experienced medical professional. Your current role is a doctor who is examining a patient to answer the [Question]. The patient's description is in [Description of the patient].
You should pretend not to know the content in [symptoms, medical history, and test results] and get them through reasoning step by step in the chain to solve the [Question].
You should reason about the [Question] step by step and get content in [symptoms, medical history, and test results] during the reasoning process. Each question to access [symptoms, medical history, and test results] should arise naturally as part of the logical flow, ensuring that it aligns with the clinical reasoning process.
For each node of the chain, you should generate a query, starting with [Query number]. You must give the answer for [Query number], starting with [Answer number].
Each node of the chain can be a query and answer to the content in [symptoms, medical history, and test results], or a query and answer to related medical knowledge.
You should mark the queries that ask for the content in [symptoms, medical history, and test results] with [<Physician> Question].
You should mark the queries that ask for the related objective medical knowledge with [<LLM> Question].
There should be strict logical connections between nodes, such as relevant medical knowledge or your medical experience
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
You must give the final answer by "So the final answer is ".
[Description of the patient]: 
[symptoms, medical history, and test results]: 
[Question]:

For example:
### User: [Description of the patient]: A 62-year-old woman is currently under regular medical supervision to address her heart health and related concerns. She experiences occasional episodes that affect her overall comfort and is actively participating in her treatment plan to enhance her quality of life and manage her heart condition effectively. 
[symptoms, medical history, and test results]:  \nSymptoms: Lightheadedness and palpitations occurring episodically.  \nMedical history: Myocardial infarction 6 months ago; NYHA class II chronic heart failure; diagnosed with grade I arterial hypertension 4 years ago.  \nMedications: Aspirin 81 mg, atorvastatin 10 mg, enalapril 10 mg, and metoprolol 200 mg daily.  \nVitals: Blood pressure 135/90 mm Hg; heart rate 125/min; respiratory rate 14/min; temperature 36.5\u00b0C (97.7\u00b0F).  \nCardiopulmonary examination: Irregular heart rhythm and decreased S1 intensity.  \nEchocardiography: Left ventricular ejection fraction of 39%.
[Question]: Which of the following drugs is the best choice for rate control in this patient? A: Atenolol B: Verapamil C: Diltiazem D: Propafenone E: Digoxin
### Assistant: [<Physician> Question 1]: What are the patient's initial symptoms related to heart health?
[Answer 2]: The patient has had some lightheadedness and palpitations recently.
[<LLM> Question 2]: What condition could explain the patient's symptoms of lightheadedness and palpitations?
[Answer 2]: Lightheadedness and palpitations could be caused by arrhythmias, such as atrial fibrillation (AF), or other cardiovascular issues like heart failure exacerbation or ischemia. Let’s confirm if the patient has signs of arrhythmia.
[<Physician> Question 3]: What is the patient’s heart rate and rhythm?
[Answer 3]: The patient’s heart rate is 125 bpm, and her rhythm is irregular. This supports a diagnosis of atrial fibrillation (AF) causing rapid ventricular response. Rate control is a priority in managing this condition.
[<Physician> Question 4]: Does the patient have underlying cardiac conditions that influence treatment decisions?
[Answer 4]: Yes, the patient has a history of myocardial infarction 6 months ago, NYHA class II chronic heart failure with reduced ejection fraction (HFrEF, EF 39%), and hypertension. These conditions impact the choice of medications for rate control.
[<Physician> Question 5]: Are there contraindications to using certain rate control medications in this patient?
[Answer 5]: Non-dihydropyridine calcium channel blockers like verapamil and diltiazem are contraindicated in HFrEF due to their negative inotropic effects, which can worsen heart failure. Propafenone, a rhythm control drug, is also unsuitable due to proarrhythmic risks in structural heart disease.
[<Physician> Question 6]: What medications is the patient currently taking, and do they address rate control?
[Answer 6]: The patient is on metoprolol 200 mg daily, which is a beta-blocker commonly used for rate control in AF and heart failure. However, her heart rate of 125 bpm suggests suboptimal rate control, indicating the need for an additional or alternative therapy.
[<LLM> Question 7]: Why might digoxin be a good option in this patient?
[Answer 7]: Digoxin slows the ventricular rate in AF by enhancing vagal tone without adversely affecting cardiac output, making it particularly suitable for patients with HFrEF. It can be used as adjunctive therapy to improve rate control in this patient.
[Final Content]:
The patient has atrial fibrillation with rapid ventricular response (heart rate 125 bpm) [3].
She has underlying HFrEF and a history of myocardial infarction, influencing the choice of rate control medications [4].
Non-dihydropyridine calcium channel blockers and propafenone are contraindicated in this patient [5].
Atenolol is less effective in heart failure compared to her current beta-blocker (metoprolol) [6].
Digoxin is a safe and effective option for rate control in AF with HFrEF [7].
So the final answer is E: Digoxin.

### User: [Description of the patient]: A 46-year-old woman is currently undergoing treatment for a condition that has significantly affected her vision and overall well-being. She has been experiencing various symptoms that have emerged over the past few months, and she is in the process of working with her healthcare team to address these challenges while also managing some recent positive changes in her lifestyle
[symptoms, medical history, and test results]: Symptoms: 2-week history of diplopia; ocular pain when reading; 3-month history of amenorrhea, hot flashes, and increased sweating; fine resting tremor of the hands.  \nMedical history: Overweight all her adult life; lost 6.8-kg (15-lb) in the past 2 months.  \nVital signs: Pulse 110/min; blood pressure 148/98 mm Hg.  \nPhysical examination: Moist palms; nontender, enlarged thyroid gland; ophthalmologic findings of globe prominence, bilateral lid retraction, conjunctival injection, and inability to converge the eyes; pain-free extraocular muscle movement; visual acuity 20/20 bilaterally; deep tendon reflexes 3+ with shortened relaxation phase.
[Question]: Which of the following is the most likely cause of this patient's ocular complaints? A: Granulomatous inflammation of the cavernous sinus B: Abnormal communication between the cavernous sinus and the internal carotid artery C: Glycosaminoglycan accumulation in the orbit D: Bacterial infection of the orbital contents E: Sympathetic hyperactivity of levator palpebrae superioris
### Assistant: [<Physician> Question 1]: What are the patient's initial symptoms related to her vision and well-being?
[Answer 1]: The patient reports a 2-week history of diplopia (double vision) and ocular pain when reading, along with other systemic symptoms like amenorrhea, hot flashes, and increased sweating.
[<LLM> Question 2]: What could cause diplopia and ocular discomfort in this patient?
[Answer 2]: Diplopia and ocular discomfort can be caused by various conditions, including thyroid eye disease (Graves' ophthalmopathy), cranial nerve palsies, and other orbital pathologies. Given her systemic symptoms, it may be worth investigating if thyroid dysfunction is involved.
[<Physician> Question 3]: Is there any evidence of thyroid dysfunction in the patient's clinical presentation?
[Answer 3]: Yes, the patient has an enlarged, nontender thyroid gland and associated symptoms indicating hyperthyroidism, such as increased sweating and weight loss, which is often seen in Graves’ disease.
[<Physician> Question 4]: What specific findings in this patient suggest the diagnosis of Graves' disease?
[Answer 4]: The patient exhibits exophthalmos (globe prominence), bilateral lid retraction, and an inability to converge her eyes, all of which are indicative of thyroid-associated ophthalmopathy, commonly associated with Graves' disease.
[<LLM> Question 5]: What role do glycosaminoglycans play in the ocular manifestations associated with Graves' disease?
[Answer 5]: Glycosaminoglycans, especially hyaluronic acid, accumulate in the orbit due to autoimmune processes in Graves’ disease, leading to edema and expansion of extraocular muscles, which can result in diplopia and other ocular symptoms.
[<LLM> Question 6]: Given the findings, what is the most likely underlying cause of this patient's ocular complaints?
[Answer 6]: The ocular complaints primarily stem from the accumulation of glycosaminoglycans in the orbit as a result of Graves' disease, which affects the extraocular muscles and the surrounding tissues.
[Final Content]: 
The patient reports diplopia and ocular pain, signifying possible ocular pathology [1]. 
She has symptoms consistent with hyperthyroidism and Graves' disease, including globe prominence and other ocular signs [3]. 
Glycosaminoglycan accumulation typically occurs in the context of Graves' disease, leading to the associated ocular manifestations such as diplopia [5].
So the final answer is C: Glycosaminoglycan accumulation in the orbit."""


Prompt_gpt_ask_assistant_v3_with_mark = """
You are an experienced medical professional. Your current role is a doctor who is examining a patient to answer the [Question]. The patient's description is in [Description of the patient].
You should pretend not to know the content in [symptoms, medical history, and test results] and get them through reasoning step by step in the chain to solve the [Question].
You should reason about the [Question] step by step and get content in [symptoms, medical history, and test results] during the reasoning process. Each question to access [symptoms, medical history, and test results] should arise naturally as part of the logical flow, ensuring that it aligns with the clinical reasoning process.
For each node of the chain, you should generate a query, starting with [Query number]. You must give the answer for [Query number], starting with [Answer number].
Each node of the chain can be a query and answer to the content in [symptoms, medical history, and test results], or a query and answer to related medical knowledge.
You should mark the queries that ask for the content in [symptoms, medical history, and test results] with [<Physician> Question].
You should mark the queries that ask for the related objective medical knowledge with [<LLM> Question].
There should be strict logical connections between nodes, such as relevant medical knowledge or your medical experience
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
You must give the final answer by "So the final answer is ".
[Description of the patient]: 
[symptoms, medical history, and test results]: 
[Question]:

For example:
### User: [Description of the patient]: A 62-year-old woman is currently under regular medical supervision to address her heart health and related concerns. She experiences occasional episodes that affect her overall comfort and is actively participating in her treatment plan to enhance her quality of life and manage her heart condition effectively. 
[symptoms, medical history, and test results]:  \nSymptoms: Lightheadedness and palpitations occurring episodically.  \nMedical history: Myocardial infarction 6 months ago; NYHA class II chronic heart failure; diagnosed with grade I arterial hypertension 4 years ago.  \nMedications: Aspirin 81 mg, atorvastatin 10 mg, enalapril 10 mg, and metoprolol 200 mg daily.  \nVitals: Blood pressure 135/90 mm Hg; heart rate 125/min; respiratory rate 14/min; temperature 36.5\u00b0C (97.7\u00b0F).  \nCardiopulmonary examination: Irregular heart rhythm and decreased S1 intensity.  \nEchocardiography: Left ventricular ejection fraction of 39%.
[Question]: Which of the following drugs is the best choice for rate control in this patient? A: Atenolol B: Verapamil C: Diltiazem D: Propafenone E: Digoxin
### Assistant: [<Physician> Question 1]: What are the patient's initial symptoms related to heart health?
[Answer 1]: The patient has some lightheadedness
[<Physician> Question 2]: Whether the patient has palpitations?
[Answer 2]: Yes, the patient has palpitations recently.
[<LLM> Question 3]: What condition could explain the patient's symptoms of lightheadedness and palpitations?
[Answer 3]: Lightheadedness and palpitations could be caused by arrhythmias, such as atrial fibrillation (AF), or other cardiovascular issues like heart failure exacerbation or ischemia. Let’s confirm if the patient has signs of arrhythmia.
[<Physician> Question 4]: What is the patient’s heart rate and rhythm?
[Answer 4]: The patient’s heart rate is 125 bpm, and her rhythm is irregular. This supports a diagnosis of atrial fibrillation (AF) causing rapid ventricular response. Rate control is a priority in managing this condition.
[<Physician> Question 5]: Does the patient have underlying cardiac conditions that influence treatment decisions?
[Answer 5]: Yes, the patient has a history of myocardial infarction 6 months ago, NYHA class II chronic heart failure with reduced ejection fraction (HFrEF, EF 39%), and hypertension. These conditions impact the choice of medications for rate control.
[<Physician> Question 6]: Are there contraindications to using certain rate control medications in this patient?
[Answer 6]: Non-dihydropyridine calcium channel blockers like verapamil and diltiazem are contraindicated in HFrEF due to their negative inotropic effects, which can worsen heart failure. Propafenone, a rhythm control drug, is also unsuitable due to proarrhythmic risks in structural heart disease.
[<Physician> Question 7]: What medications is the patient currently taking, and do they address rate control?
[Answer 7]: The patient is on metoprolol 200 mg daily, which is a beta-blocker commonly used for rate control in AF and heart failure. However, her heart rate of 125 bpm suggests suboptimal rate control, indicating the need for an additional or alternative therapy.
[<LLM> Question 8]: Why might digoxin be a good option in this patient?
[Answer 8]: Digoxin slows the ventricular rate in AF by enhancing vagal tone without adversely affecting cardiac output, making it particularly suitable for patients with HFrEF. It can be used as adjunctive therapy to improve rate control in this patient.
[Final Content]:
The patient has symptoms of dizziness and palpitations. [1,2]
The patient has atrial fibrillation with rapid ventricular response (heart rate 125 bpm) [4].
She has underlying HFrEF and a history of myocardial infarction, influencing the choice of rate control medications [5].
Non-dihydropyridine calcium channel blockers and propafenone are contraindicated in this patient [6].
Atenolol is less effective in heart failure compared to her current beta-blocker (metoprolol) [7].
Digoxin is a safe and effective option for rate control in AF with HFrEF [8].
So the final answer is Digoxin.

### User: [Description of the patient]: A 46-year-old woman is currently undergoing treatment for a condition that has significantly affected her vision and overall well-being. She has been experiencing various symptoms that have emerged over the past few months, and she is in the process of working with her healthcare team to address these challenges while also managing some recent positive changes in her lifestyle
[symptoms, medical history, and test results]: Symptoms: 2-week history of diplopia; ocular pain when reading; 3-month history of amenorrhea, hot flashes, and increased sweating; fine resting tremor of the hands.  \nMedical history: Overweight all her adult life; lost 6.8-kg (15-lb) in the past 2 months.  \nVital signs: Pulse 110/min; blood pressure 148/98 mm Hg.  \nPhysical examination: Moist palms; nontender, enlarged thyroid gland; ophthalmologic findings of globe prominence, bilateral lid retraction, conjunctival injection, and inability to converge the eyes; pain-free extraocular muscle movement; visual acuity 20/20 bilaterally; deep tendon reflexes 3+ with shortened relaxation phase.
[Question]: Which of the following is the most likely cause of this patient's ocular complaints? A: Granulomatous inflammation of the cavernous sinus B: Abnormal communication between the cavernous sinus and the internal carotid artery C: Glycosaminoglycan accumulation in the orbit D: Bacterial infection of the orbital contents E: Sympathetic hyperactivity of levator palpebrae superioris
### Assistant: [<Physician> Question 1]: What are the patient's initial symptoms related to her vision and well-being?
[Answer 1]: The patient reports a 2-week history of diplopia (double vision) and ocular pain when reading.
[<LLM> Question 2]: What disease may cause binocular double vision and eye pain?
[Answer 2]:  Diplopia and ocular discomfort can be caused by various conditions, including thyroid eye disease (Graves' ophthalmopathy), cranial nerve palsies, and other orbital pathologies. These disorders can cause double vision and eye discomfort. They may also be accompanied by systemic symptoms such as hot flashes and excessive sweating.
[<Physician> Question 3]: Does the patient has systemic symptoms, such as hot flashes, excessive sweating, menstrual disorders, etc.? 
[Answer 3]: Yes, the patient reports the systemic symptoms like amenorrhea, hot flashes, and increased sweating.
[<Physician> Question 4]:  Given her systemic symptoms, it may be worth investigating if thyroid dysfunction is involved. Is there any evidence of thyroid dysfunction in the patient's clinical presentation?
[Answer 4]: Yes, the patient has an enlarged, nontender thyroid gland and associated symptoms indicating hyperthyroidism, such as increased sweating and weight loss, which is often seen in Graves’ disease.
[<Physician> Question 5]: What specific findings in this patient suggest the diagnosis of Graves' disease?
[Answer 5]: The patient exhibits exophthalmos (globe prominence), bilateral lid retraction, and an inability to converge her eyes, all of which are indicative of thyroid-associated ophthalmopathy, commonly associated with Graves' disease.
[<LLM> Question 6]: What role do glycosaminoglycans play in the ocular manifestations associated with Graves' disease?
[Answer 6]: Glycosaminoglycans, especially hyaluronic acid, accumulate in the orbit due to autoimmune processes in Graves’ disease, leading to edema and expansion of extraocular muscles, which can result in diplopia and other ocular symptoms.
[<LLM> Question 7]: Given the findings, what is the most likely underlying cause of this patient's ocular complaints?
[Answer 7]: The ocular complaints primarily stem from the accumulation of glycosaminoglycans in the orbit as a result of Graves' disease, which affects the extraocular muscles and the surrounding tissues.
[Final Content]: 
The patient reports diplopia and ocular pain, signifying possible ocular pathology [1,3]. 
She has symptoms consistent with hyperthyroidism and Graves' disease, including globe prominence and other ocular signs [5]. 
Glycosaminoglycan accumulation typically occurs in the context of Graves' disease, leading to the associated ocular manifestations such as diplopia [6,7].
So the final answer is Glycosaminoglycan accumulation in the orbit."""


Prompt_gpt_ask_assistant_v3_with_mark_open_end = """
You are an experienced medical professional. Your current role is a doctor who is examining a patient to answer the [Question]. The patient's description is in [Description of the patient].
You should pretend not to know the content in [symptoms, medical history, and test results] and get them through reasoning step by step in the chain to solve the [Question].
You should reason about the [Question] step by step and get content in [symptoms, medical history, and test results] during the reasoning process. Each question to access [symptoms, medical history, and test results] should arise naturally as part of the logical flow, ensuring that it aligns with the clinical reasoning process.
For each node of the chain, you should generate a query, starting with [Query number]. You must give the answer for [Query number], starting with [Answer number].
Each node of the chain can be a query and answer to the content in [symptoms, medical history, and test results], or a query and answer to related medical knowledge.
You should mark the queries that ask for the content in [symptoms, medical history, and test results] with [<Physician> Question].
You should mark the queries that ask for the related objective medical knowledge with [<LLM> Question].
There should be strict logical connections between nodes, such as relevant medical knowledge or your medical experience
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
You must give the final answer by "So the final answer is ".
[Description of the patient]: 
[symptoms, medical history, and test results]: 
[Question]:

For example:
Example 1 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
User: [Description of the patient]: A 62-year-old woman is currently under regular medical supervision to address her heart health and related concerns. She experiences occasional episodes that affect her overall comfort and is actively participating in her treatment plan to enhance her quality of life and manage her heart condition effectively. 
[symptoms, medical history, and test results]:  \nSymptoms: Lightheadedness and palpitations occurring episodically.  \nMedical history: Myocardial infarction 6 months ago; NYHA class II chronic heart failure; diagnosed with grade I arterial hypertension 4 years ago.  \nMedications: Aspirin 81 mg, atorvastatin 10 mg, enalapril 10 mg, and metoprolol 200 mg daily.  \nVitals: Blood pressure 135/90 mm Hg; heart rate 125/min; respiratory rate 14/min; temperature 36.5\u00b0C (97.7\u00b0F).  \nCardiopulmonary examination: Irregular heart rhythm and decreased S1 intensity.  \nEchocardiography: Left ventricular ejection fraction of 39%.
[Question]: What drug is the best choice for rate control in this patient?
Assistant: 

[<Physician> Question 1]: What are the patient's initial symptoms related to heart health?
[Answer 1]: The patient has some lightheadedness
[<Physician> Question 2]: Whether the patient has palpitations?
[Answer 2]: Yes, the patient has palpitations recently.
[<LLM> Question 3]: What condition could explain the patient's symptoms of lightheadedness and palpitations?
[Answer 3]: Lightheadedness and palpitations could be caused by arrhythmias, such as atrial fibrillation (AF), or other cardiovascular issues like heart failure exacerbation or ischemia. Let’s confirm if the patient has signs of arrhythmia.
[<Physician> Question 4]: What is the patient’s heart rate and rhythm?
[Answer 4]: The patient’s heart rate is 125 bpm, and her rhythm is irregular. This supports a diagnosis of atrial fibrillation (AF) causing rapid ventricular response. Rate control is a priority in managing this condition.
[<Physician> Question 5]: Does the patient have underlying cardiac conditions that influence treatment decisions?
[Answer 5]: Yes, the patient has a history of myocardial infarction 6 months ago, NYHA class II chronic heart failure with reduced ejection fraction (HFrEF, EF 39%), and hypertension. These conditions impact the choice of medications for rate control.
[<Physician> Question 6]: Are there contraindications to using certain rate control medications in this patient?
[Answer 6]: Non-dihydropyridine calcium channel blockers like verapamil and diltiazem are contraindicated in HFrEF due to their negative inotropic effects, which can worsen heart failure. Propafenone, a rhythm control drug, is also unsuitable due to proarrhythmic risks in structural heart disease.
[<Physician> Question 7]: What medications is the patient currently taking, and do they address rate control?
[Answer 7]: The patient is on metoprolol 200 mg daily, which is a beta-blocker commonly used for rate control in AF and heart failure. However, her heart rate of 125 bpm suggests suboptimal rate control, indicating the need for an additional or alternative therapy.
[<LLM> Question 8]: Why might digoxin be a good option in this patient?
[Answer 8]: Digoxin slows the ventricular rate in AF by enhancing vagal tone without adversely affecting cardiac output, making it particularly suitable for patients with HFrEF. It can be used as adjunctive therapy to improve rate control in this patient.
[Final Content]:
The patient has symptoms of dizziness and palpitations. [1,2]
The patient has atrial fibrillation with rapid ventricular response (heart rate 125 bpm) [4].
She has underlying HFrEF and a history of myocardial infarction, influencing the choice of rate control medications [5].
Non-dihydropyridine calcium channel blockers and propafenone are contraindicated in this patient [6].
Atenolol is less effective in heart failure compared to her current beta-blocker (metoprolol) [7].
Digoxin is a safe and effective option for rate control in AF with HFrEF [8].
So the final answer is Digoxin.

Example 2 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
User: [Description of the patient]: A 46-year-old woman is currently undergoing treatment for a condition that has significantly affected her vision and overall well-being. She has been experiencing various symptoms that have emerged over the past few months, and she is in the process of working with her healthcare team to address these challenges while also managing some recent positive changes in her lifestyle
[symptoms, medical history, and test results]: Symptoms: 2-week history of diplopia; ocular pain when reading; 3-month history of amenorrhea, hot flashes, and increased sweating; fine resting tremor of the hands.  \nMedical history: Overweight all her adult life; lost 6.8-kg (15-lb) in the past 2 months.  \nVital signs: Pulse 110/min; blood pressure 148/98 mm Hg.  \nPhysical examination: Moist palms; nontender, enlarged thyroid gland; ophthalmologic findings of globe prominence, bilateral lid retraction, conjunctival injection, and inability to converge the eyes; pain-free extraocular muscle movement; visual acuity 20/20 bilaterally; deep tendon reflexes 3+ with shortened relaxation phase.
[Question]: What is the most likely cause of this patient's ocular complaints?
Assistant: [<Physician> Question 1]: What are the patient's initial symptoms related to her vision and well-being?
[Answer 1]: The patient reports a 2-week history of diplopia (double vision) and ocular pain when reading.
[<LLM> Question 2]: What disease may cause binocular double vision and eye pain?
[Answer 2]:  Diplopia and ocular discomfort can be caused by various conditions, including thyroid eye disease (Graves' ophthalmopathy), cranial nerve palsies, and other orbital pathologies. These disorders can cause double vision and eye discomfort. They may also be accompanied by systemic symptoms such as hot flashes and excessive sweating.
[<Physician> Question 3]: Does the patient has systemic symptoms, such as hot flashes, excessive sweating, menstrual disorders, etc.? 
[Answer 3]: Yes, the patient reports the systemic symptoms like amenorrhea, hot flashes, and increased sweating.
[<Physician> Question 4]:  Given her systemic symptoms, it may be worth investigating if thyroid dysfunction is involved. Is there any evidence of thyroid dysfunction in the patient's clinical presentation?
[Answer 4]: Yes, the patient has an enlarged, nontender thyroid gland and associated symptoms indicating hyperthyroidism, such as increased sweating and weight loss, which is often seen in Graves’ disease.
[<Physician> Question 5]: What specific findings in this patient suggest the diagnosis of Graves' disease?
[Answer 5]: The patient exhibits exophthalmos (globe prominence), bilateral lid retraction, and an inability to converge her eyes, all of which are indicative of thyroid-associated ophthalmopathy, commonly associated with Graves' disease.
[<LLM> Question 6]: What role do glycosaminoglycans play in the ocular manifestations associated with Graves' disease?
[Answer 6]: Glycosaminoglycans, especially hyaluronic acid, accumulate in the orbit due to autoimmune processes in Graves’ disease, leading to edema and expansion of extraocular muscles, which can result in diplopia and other ocular symptoms.
[<LLM> Question 7]: Given the findings, what is the most likely underlying cause of this patient's ocular complaints?
[Answer 7]: The ocular complaints primarily stem from the accumulation of glycosaminoglycans in the orbit as a result of Graves' disease, which affects the extraocular muscles and the surrounding tissues.
[Final Content]: 
The patient reports diplopia and ocular pain, signifying possible ocular pathology [1,3]. 
She has symptoms consistent with hyperthyroidism and Graves' disease, including globe prominence and other ocular signs [5]. 
Glycosaminoglycan accumulation typically occurs in the context of Graves' disease, leading to the associated ocular manifestations such as diplopia [6,7].
So the final answer is Glycosaminoglycan accumulation in the orbit.

Example 3 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
User: [Description of the patient]: A 7-year-old girl is currently under medical care due to a recent illness characterized by discomfort and visible signs on her skin. Following an incident with a cat bite, her parents have sought help to address her symptoms and ensure a full recovery. 
[symptoms, medical history, and test results]:  Symptoms: Red papules over left thigh; swelling in right axilla; fever of 38.6\u00b0C (101.4\u00b0F).  \nMedical history: Cat bite on left thigh 2 weeks ago.  \nVitals: Pulse 90/min; respirations 22/min.  \nPhysical examination: Hepatosplenomegaly; healing area of erythema on left hand.  \nLaboratory studies: Hemoglobin 12.9 gm/dL; leukocyte count 9,300/mm\u00b3; platelet count 167,000/mm\u00b3; ESR 12 mm/hr.  \n\n
[Question]: What is the most appropriate next step in management?
Assistant: [<Physician> Question 1]: What are the patient's initial symptoms following the cat bite?
[Answer 1]: The patient has red papules over her left thigh, swelling in the right axilla, and a fever of 38.6°C (101.4°F).
[<LLM> Question 2]: What are common complications or infections that can arise from a cat bite?
[Answer 2]: Cat bites can lead to infections such as cellulitis or abscess formation, often due to bacteria like Pasteurella multocida, and can also cause lymphadenopathy. Monitoring for systemic signs of infection, especially in pediatrics, is crucial.
[<Physician> Question 3]: How long ago did the cat bite occur?
[Answer 3]: The cat bite occurred 2 weeks ago.
[<LLM> Question 4]: Given the time frame and symptoms, what is the potential concern regarding her current condition?
[Answer 4]: The timing of the symptoms and the cat bite raises suspicion for an infection that may require intervention, especially if the patient is showing signs of systemic infection such as fever and localized swelling. 
[<Physician> Question 5]: What does the physical examination reveal, particularly concerning the lymphatic system?
[Answer 5]: The physical examination shows hepatosplenomegaly and a healing area of erythema on the left hand, indicating potential systemic involvement and local infection at the bite site.
[<Physician> Question 6]: Based on her blood test results, what are the key findings to note?
[Answer 6]: The laboratory studies show a hemoglobin level of 12.9 gm/dL, a leukocyte count of 9,300/mm³, a platelet count of 167,000/mm³, and an erythrocyte sedimentation rate (ESR) of 12 mm/hr. This indicates a relatively normal leukocyte count and platelet count, with slight inflammation suggested by the ESR.
[<LLM> Question 7]: Given this information, what is the appropriate initial step in management for a child with symptoms following a potential cat bite infection?
[Answer 7]: The most appropriate initial step in management would be to initiate empiric antibiotic therapy, addressing the risk of infection from the cat bite, given the child's symptoms and the recent history.
[Final Content]: 
The patient has red papules on her thigh, swelling in the right axilla, and a fever, indicating possible infection following a cat bite [1]. 
She has hepatosplenomegaly and erythema, suggesting systemic infection [5]. 
Her laboratory findings largely within normal limits indicate no severe leukopenia or thrombocytopenia, but the slight increase in ESR suggests inflammation [6]. 
Given the clinical context and the symptoms following the cat bite, empiric antibiotic therapy is warranted [7].
So the final answer is Initiate empiric antibiotic therapy.

Example 4 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
User: [Description of the patient]: A 35-year-old woman is experiencing ongoing treatment for a complex condition that has contributed to fatigue and discomfort, affecting her daily life and mobility. She has noticeable skin changes and is being carefully monitored by her healthcare team to address her symptoms and enhance her quality of life.
[symptoms, medical history, and test results]: Symptoms: 3-month history of progressive fatigue; shortness of breath; pain in knees and ankles; mild hepatomegaly; tender, red nodules on shins; purple, indurated lesions on nose, nasolabial fold, and cheeks.  \nTest results: Liver biopsy shows scattered aggregations of multinucleated giant cells with cytoplasmic inclusions and eosinophilic needle-shaped structures arranged in a star-like pattern. 
[Question]: What is the most likely cause of this patient's symptoms?
Assistant: [<Physician> Question 1]: What are the patient's key symptoms related to her condition affecting daily life and mobility?
[Answer 1]: The patient has a 3-month history of progressive fatigue, shortness of breath, pain in her knees and ankles, mild hepatomegaly, and tender red nodules on her shins, along with purplish, indurated lesions on her nose, nasolabial fold, and cheeks.
[<LLM> Question 2]: What could cause the combination of progressive fatigue, joint pain, mild hepatomegaly, and specific skin lesions?
[Answer 2]: Conditions such as systemic lupus erythematosus (SLE), dermatomyositis, or other autoimmune diseases could present with these symptoms. Specifically, we should consider if there is a connection between the skin findings and the systemic symptoms.
[<Physician> Question 3]: How do the specific skin lesions correlate with systemic conditions?
[Answer 3]: The tender red nodules on the shins and purple indurated lesions, particularly on sun-exposed areas like the nose and cheeks, suggest possible dermatomyositis or another connective tissue disease.
[<Physician> Question 4]: Are there any notable findings from the liver biopsy that could help identify the underlying cause of these symptoms?
[Answer 4]: Yes, the liver biopsy shows scattered aggregations of multinucleated giant cells with cytoplasmic inclusions and eosinophilic needle-shaped structures arranged in a star-like pattern. This finding is characteristic of a specific condition.
[<LLM> Question 5]: Given the histological findings, what condition could the liver biopsy results indicate?
[Answer 5]: The biopsy results strongly suggest a diagnosis of non-alcoholic steatohepatitis (NASH) or possibly a metabolic condition such as a form of hepatitis, particularly one associated with autoimmune features.
[<LLM> Question 6]: What systemic condition is associated with similar multicellular immune response features that may relate to the reported symptoms?
[Answer 6]: Conditions like sarcoidosis or other granulomatous diseases could present with multinucleated giant cells and may explain some of the systemic symptoms alongside skin manifestations.
[Final Content]: 
The patient presents with progressive fatigue, joint pain, mild hepatomegaly, and distinctive skin lesions, indicating a complex systemic condition [1-3]. 
The liver biopsy reveals aggregations of multinucleated giant cells and eosinophilic structures, suggesting a specific etiology potentially related to an autoimmune or granulomatous process [4,5]. 
Given the skin and systemic symptoms, autoimmune conditions or metabolic syndromes like NASH emerge as underlying causes with multinucleated giant cell formation hinting at systemic involvement [6].
So the final answer is likely an autoimmune condition such as dermatomyositis or non-alcoholic steatohepatitis (NASH) leading to systemic symptoms, liver involvement, and skin changes.
"""


Prompt_gpt_ask_assistant_v3_with_mark_open_end_dpo = """
You are an experienced medical professional. Your current role is a doctor who is examining a patient to answer the [Question]. The patient's description is in [Description of the patient].
You should pretend not to know the content in [symptoms, medical history, and test results] and get them through reasoning step by step in the chain to solve the [Question].
You should reason about the [Question] step by step and get content in [symptoms, medical history, and test results] during the reasoning process. Each question to access [symptoms, medical history, and test results] should arise naturally as part of the logical flow, ensuring that it aligns with the clinical reasoning process.
For each node of the chain, you should generate a query, starting with [Query number]. You must give the answer for [Query number], starting with [Answer number].
Each node of the chain can be a query and answer to the content in [symptoms, medical history, and test results], or a query and answer to related medical knowledge.
You should mark the queries that ask for the content in [symptoms, medical history, and test results] with [<Physician> Question].
You should mark the queries that ask for the related objective medical knowledge with [<LLM> Question].
There should be strict logical connections between nodes, such as relevant medical knowledge or your medical experience
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
You must give the final answer by "So the final answer is ".
[Description of the patient]: 
[symptoms, medical history, and test results]: 
[Question]:

For example:
Example 1 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
User: [Description of the patient]: A 62-year-old woman is currently under regular medical supervision to address her heart health and related concerns. She experiences occasional episodes that affect her overall comfort and is actively participating in her treatment plan to enhance her quality of life and manage her heart condition effectively. 
[symptoms, medical history, and test results]:  \nSymptoms: Lightheadedness and palpitations occurring episodically.  \nMedical history: Myocardial infarction 6 months ago; NYHA class II chronic heart failure; diagnosed with grade I arterial hypertension 4 years ago.  \nMedications: Aspirin 81 mg, atorvastatin 10 mg, enalapril 10 mg, and metoprolol 200 mg daily.  \nVitals: Blood pressure 135/90 mm Hg; heart rate 125/min; respiratory rate 14/min; temperature 36.5\u00b0C (97.7\u00b0F).  \nCardiopulmonary examination: Irregular heart rhythm and decreased S1 intensity.  \nEchocardiography: Left ventricular ejection fraction of 39%.
[Question]: What drug is the best choice for rate control in this patient?
Assistant: 

[<Physician> Question 1]: What are the patient's initial symptoms related to heart health?
[Answer 1]: The patient has some lightheadedness
[<Physician> Question 2]: Whether the patient has palpitations?
[Answer 2]: Yes, the patient has palpitations recently.
[<LLM> Question 3]: What condition could explain the patient's symptoms of lightheadedness and palpitations?
[Answer 3]: Lightheadedness and palpitations could be caused by arrhythmias, such as atrial fibrillation (AF), or other cardiovascular issues like heart failure exacerbation or ischemia. Let’s confirm if the patient has signs of arrhythmia.
[<Physician> Question 4]: What is the patient’s heart rate and rhythm?
[Answer 4]: The patient’s heart rate is 125 bpm, and her rhythm is irregular. This supports a diagnosis of atrial fibrillation (AF) causing rapid ventricular response. Rate control is a priority in managing this condition.
[<Physician> Question 5]: Does the patient have underlying cardiac conditions that influence treatment decisions?
[Answer 5]: Yes, the patient has a history of myocardial infarction 6 months ago, NYHA class II chronic heart failure with reduced ejection fraction (HFrEF, EF 39%), and hypertension. These conditions impact the choice of medications for rate control.
[<Physician> Question 6]: Are there contraindications to using certain rate control medications in this patient?
[Answer 6]: Non-dihydropyridine calcium channel blockers like verapamil and diltiazem are contraindicated in HFrEF due to their negative inotropic effects, which can worsen heart failure. Propafenone, a rhythm control drug, is also unsuitable due to proarrhythmic risks in structural heart disease.
[<Physician> Question 7]: What medications is the patient currently taking, and do they address rate control?
[Answer 7]: The patient is on metoprolol 200 mg daily, which is a beta-blocker commonly used for rate control in AF and heart failure. However, her heart rate of 125 bpm suggests suboptimal rate control, indicating the need for an additional or alternative therapy.
[<LLM> Question 8]: Why might digoxin be a good option in this patient?
[Answer 8]: Digoxin slows the ventricular rate in AF by enhancing vagal tone without adversely affecting cardiac output, making it particularly suitable for patients with HFrEF. It can be used as adjunctive therapy to improve rate control in this patient.
[Final Content]:
The patient has symptoms of dizziness and palpitations. [1,2]
The patient has atrial fibrillation with rapid ventricular response (heart rate 125 bpm) [4].
She has underlying HFrEF and a history of myocardial infarction, influencing the choice of rate control medications [5].
Non-dihydropyridine calcium channel blockers and propafenone are contraindicated in this patient [6].
Atenolol is less effective in heart failure compared to her current beta-blocker (metoprolol) [7].
Digoxin is a safe and effective option for rate control in AF with HFrEF [8].
So the final answer is Digoxin.

Example 2 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
User: [Description of the patient]: A 46-year-old woman is currently undergoing treatment for a condition that has significantly affected her vision and overall well-being. She has been experiencing various symptoms that have emerged over the past few months, and she is in the process of working with her healthcare team to address these challenges while also managing some recent positive changes in her lifestyle
[symptoms, medical history, and test results]: Symptoms: 2-week history of diplopia; ocular pain when reading; 3-month history of amenorrhea, hot flashes, and increased sweating; fine resting tremor of the hands.  \nMedical history: Overweight all her adult life; lost 6.8-kg (15-lb) in the past 2 months.  \nVital signs: Pulse 110/min; blood pressure 148/98 mm Hg.  \nPhysical examination: Moist palms; nontender, enlarged thyroid gland; ophthalmologic findings of globe prominence, bilateral lid retraction, conjunctival injection, and inability to converge the eyes; pain-free extraocular muscle movement; visual acuity 20/20 bilaterally; deep tendon reflexes 3+ with shortened relaxation phase.
[Question]: What is the most likely cause of this patient's ocular complaints?
Assistant: [<Physician> Question 1]: What are the patient's initial symptoms related to her vision and well-being?
[Answer 1]: The patient reports a 2-week history of diplopia (double vision) and ocular pain when reading.
[<LLM> Question 2]: What disease may cause binocular double vision and eye pain?
[Answer 2]:  Diplopia and ocular discomfort can be caused by various conditions, including thyroid eye disease (Graves' ophthalmopathy), cranial nerve palsies, and other orbital pathologies. These disorders can cause double vision and eye discomfort. They may also be accompanied by systemic symptoms such as hot flashes and excessive sweating.
[<Physician> Question 3]: Does the patient has systemic symptoms, such as hot flashes, excessive sweating, menstrual disorders, etc.? 
[Answer 3]: Yes, the patient reports the systemic symptoms like amenorrhea, hot flashes, and increased sweating.
[<Physician> Question 4]:  Given her systemic symptoms, it may be worth investigating if thyroid dysfunction is involved. Is there any evidence of thyroid dysfunction in the patient's clinical presentation?
[Answer 4]: Yes, the patient has an enlarged, nontender thyroid gland and associated symptoms indicating hyperthyroidism, such as increased sweating and weight loss, which is often seen in Graves’ disease.
[<Physician> Question 5]: What specific findings in this patient suggest the diagnosis of Graves' disease?
[Answer 5]: The patient exhibits exophthalmos (globe prominence), bilateral lid retraction, and an inability to converge her eyes, all of which are indicative of thyroid-associated ophthalmopathy, commonly associated with Graves' disease.
[<LLM> Question 6]: What role do glycosaminoglycans play in the ocular manifestations associated with Graves' disease?
[Answer 6]: Glycosaminoglycans, especially hyaluronic acid, accumulate in the orbit due to autoimmune processes in Graves’ disease, leading to edema and expansion of extraocular muscles, which can result in diplopia and other ocular symptoms.
[<LLM> Question 7]: Given the findings, what is the most likely underlying cause of this patient's ocular complaints?
[Answer 7]: The ocular complaints primarily stem from the accumulation of glycosaminoglycans in the orbit as a result of Graves' disease, which affects the extraocular muscles and the surrounding tissues.
[Final Content]: 
The patient reports diplopia and ocular pain, signifying possible ocular pathology [1,3]. 
She has symptoms consistent with hyperthyroidism and Graves' disease, including globe prominence and other ocular signs [5]. 
Glycosaminoglycan accumulation typically occurs in the context of Graves' disease, leading to the associated ocular manifestations such as diplopia [6,7].
So the final answer is Glycosaminoglycan accumulation in the orbit."""



Prompt_gpt_ask_assistant_deepseek_with_mark_open_end = """
You are an experienced medical professional. Your current role is a doctor who is examining a patient to answer the [Question]. The patient's description is in [Description of the patient].
You should pretend not to know the content in [symptoms, medical history, and test results] and get them through reasoning step by step in the chain to solve the [Question].
You should reason about the [Question] step by step and get content in [symptoms, medical history, and test results] during the reasoning process. Each question to access [symptoms, medical history, and test results] should arise naturally as part of the logical flow, ensuring that it aligns with the clinical reasoning process.
For each node of the chain, you should generate a query, starting with [Query number]. You must give the answer for [Query number], starting with [Answer number].
Each node of the chain can be a query and answer to the content in [symptoms, medical history, and test results], or a query and answer to related medical knowledge.
Before generating each [Query], you should do some thinking within <sub-think> </sub-think> to clarify your motivation for generating this [Query].
You should mark the queries that ask for the content in [symptoms, medical history, and test results] with [<Physician> Question].
You should mark the queries that ask for the related objective medical knowledge with [<LLM> Question].
There should be strict logical connections between nodes, such as relevant medical knowledge or your medical experience
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
You must give the final answer by "So the final answer is ".
[Description of the patient]: 
[symptoms, medical history, and test results]: 
[Question]:

For example:

Example 1 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
Before generating each [Query], you should do some thinking within <sub-think> </sub-think> to clarify your motivation for generating this [Query].
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] and <sub-think> cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
User: [Description of the patient]: A 62-year-old woman is currently receiving treatment for a respiratory condition that has contributed to her feelings of fatigue and difficulty breathing, especially with exertion. With a significant history as a nurse and various chronic health concerns, she is actively working with her healthcare team to manage and improve her respiratory health while adjusting to her recent retirement.
[symptoms, medical history, and test results]: Symptoms: Coughing and fatigue for the past 2 years; productive cough with white phlegm; shortness of breath on exertion (walking up a flight of stairs).\nMedical history: Hypertension; hyperlipidemia; 40-year history of smoking 1 pack of cigarettes daily; recently retired from working as a nurse at a homeless shelter.\nMedications: Ramipril; fenofibrate.\nVitals: Temperature 36.5\u00b0C (97.7\u00b0F); respirations 24/min; pulse 85/min; blood pressure 140/90 mm Hg.\nPhysical examination: Scattered wheezing and rhonchi throughout both lung fields; distant heart sounds, no murmurs, rubs, or gallops.\n\n
[Question]: What is the most likely underlying cause of this patient's symptoms?
Assistant:
<think>
<sub-think 1> Okay, let's tackle this case. First, I need to understand the patient's specific respiratory symptoms and their duration. </sub-think 1>
[<Physician> Question 1]: What are the patient's primary respiratory symptoms and their duration?  
[Answer 1]: The patient has experienced a productive cough with white phlegm and shortness of breath on exertion (e.g., walking up stairs) for the past 2 years. She also reports fatigue.  
<sub-think 2> I need to consider the patient's risk factors for chronic respiratory conditions, particularly her smoking history. </sub-think 2>
[<Physician> Question 2]: What is the patient's smoking history?  
[Answer 2]: The patient has a 40-year history of smoking 1 pack of cigarettes daily.  
<sub-think 3> Given the chronic nature of her symptoms and her significant smoking history, I need to consider chronic obstructive pulmonary disease (COPD) as a likely diagnosis. I need to know if there are any physical examination findings that support this. </sub-think 3>
[<Physician> Question 3]: What are the findings on physical examination of the lungs?  
[Answer 3]: The physical examination reveals scattered wheezing and rhonchi throughout both lung fields.  
<sub-think 4> Wheezing and rhonchi are common in COPD, but I need to rule out other conditions like asthma or heart failure. I need to know if there are any signs of heart failure or other systemic issues. </sub-think 4>
[<Physician> Question 4]: Are there any signs of heart failure or other systemic issues?  
[Answer 4]: The heart sounds are distant, but there are no murmurs, rubs, or gallops. The patient has hypertension and hyperlipidemia but no overt signs of heart failure.  
<sub-think 5> The patient's symptoms, smoking history, and physical examination findings strongly suggest COPD. However, I need to confirm this with additional information, such as spirometry results or imaging. </sub-think 5>
[<Physician> Question 5]: Are there any spirometry results or imaging studies available?  
[Answer 5]: No specific spirometry results or imaging studies are mentioned in the provided information.  
<sub-think 6> Despite the lack of spirometry results, the patient's chronic symptoms, smoking history, and physical examination findings are highly suggestive of COPD. The absence of signs of heart failure or other systemic issues further supports this diagnosis. </sub-think 6>
[<LLM> Question 6]: What is the most likely diagnosis for a patient with chronic cough, shortness of breath, wheezing, and a significant smoking history?  
[Answer 6]: The most likely diagnosis is chronic obstructive pulmonary disease (COPD), particularly chronic bronchitis given the productive cough.  
</think>
<answer>
[Final Content]:  
The patient presents with chronic respiratory symptoms including a productive cough and shortness of breath on exertion [1].  
Her significant smoking history (40 years, 1 pack/day) is a major risk factor for COPD [2].  
Physical examination findings of wheezing and rhonchi support airway obstruction [3].  
The absence of signs of heart failure or other systemic issues further points to COPD [4].  
So the final answer is Chronic obstructive pulmonary disease (COPD), likely chronic bronchitis.
</answer>

Example 2 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
Before generating each [Query], you should do some thinking within <sub-think> </sub-think> to clarify your motivation for generating this [Query].
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] and <sub-think> cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
User: [Description of the patient]: A 63-year-old man is currently under medical care due to a condition that has led to increasing fatigue and challenges in daily living activities. He has a background of managing high blood pressure and cholesterol and is following a treatment plan aimed at addressing his recent health concerns and improving his overall quality of life
[symptoms, medical history, and test results]: Symptoms: Increasing generalized fatigue for 3 months; difficulty with activities of daily living; weight loss of 2.5 kg (5.5 lb) over the past month; pale conjunctivae.  \nMedical history: Hypertension and hyperlipidemia.  \nMedications: Lisinopril, hydrochlorothiazide, atorvastatin.  \nSocial history: Does not smoke; drinks two to three beers on weekends.  \nVitals: Temperature 37.1\u00b0C (98.8\u00b0F); pulse 85/min; respirations 15/min; blood pressure 125/73 mm Hg.  \nHematologic labs: Hematocrit 27.3%; leukocyte count 4500/mm\u00b3; platelet count 102,000/mm\u00b3.  \nPeripheral blood smear: Numerous blast cells staining positive for myeloperoxidase, CD33, and CD34.  \n\n
[Question]: What is the most likely diagnosis?
Assistant: 
<think> 
<sub-think 1> Okay, let's tackle this case.  First of all, I need to know the patient's specific main symptoms and duration。 </sub-think 1>
[<Physician> Question 1]: What are the patient's primary symptoms and duration of illness?  
[Answer 1]: The patient reports 3 months of increasing generalized fatigue, difficulty performing daily activities, and unintentional weight loss of 2.5 kg over the past month. Physical examination reveals pale conjunctivae.  
<sub-think 2>  I need to figure out the most likely diagnosis. Let's start by breaking down the symptoms and lab results. The key symptoms here are fatigue, weight loss, and pale conjunctivae, which suggest anemia. I need lab tests to confirm the patient's anemia. </sub-think 2>
[<Physician> Question 2]: Are there any laboratory results that suggest the patient may be anemic?
[Answer 2]: The labs confirm anemia with a hematocrit of 27.3%, which is quite low. Additionally, he has leukopenia (low white cells) and thrombocytopenia (low platelets).
<sub-think 3> The patient is an elderly person, and the lab results show that the patient's red blood cell, white blood cell, and platelet triad is low. I need to determine what disease this indicates. </sub-think 3>
[<LLM> Question 3]: What conditions typically present with pancytopenia (low hematocrit, leukocytes, and platelets) in older adults?  
[Answer 3]: Pancytopenia in this age group could indicate bone marrow failure syndromes, myelodysplastic syndromes (MDS), acute leukemias, or metastatic cancer infiltration. The presence of blast cells in peripheral blood narrows the possibilities.  
<sub-think 4> To narrow it down, I need to look at the patient's peripheral blood smear. </sub-think 4>
[<Physician> Question 4]: What specific findings were noted on the peripheral blood smear?  
[Answer 4]: The peripheral blood smear shows numerous blast cells that stain positive for myeloperoxidase, CD33, and CD34 – markers characteristic of myeloid lineage cells.  
<sub-think 5> The presence of blast cells is critical. Blast cells are immature cells, and their presence in the blood is abnormal. The positive staining for myeloperoxidase, CD33, and CD34 are markers that help identify the type of leukemia. Myeloperoxidase is typically seen in myeloid cells, so this suggests a myeloid lineage. CD33 and CD34 are markers often associated with acute myeloid leukemia (AML). </sub-think 5>
[<LLM> Question 5]: How do these cellular markers (myeloperoxidase+, CD33+, CD34+) help differentiate types of leukemia?  
[Answer 5]: Myeloperoxidase positivity indicates myeloid differentiation. CD33 is a myeloid-associated antigen, while CD34 is a stem cell marker. This combination strongly suggests acute myeloid leukemia (AML) rather than lymphoid leukemia.  
<sub-think 6> To further confirm the diagnosis, I need to know the patient's age, medical history, smoking and drinking history, and whether there are high-risk factors for acute myeloid leukemia. </sub-think 6> 
[<Physician> Question 6]: Does the patient have risk factors for hematologic malignancies?  
[Answer 6]: While the patient has hypertension and hyperlipidemia, these are not direct risk factors. His age (63 years) is a significant risk factor for AML development.  
<sub-think 7> Differential diagnoses might include other types of leukemia or myelodysplastic syndromes (MDS). However, the presence of blast cells exceeding 20% in the bone marrow (implied by their presence in peripheral blood) is a key criterion for AML rather than MDS. The markers CD33 and CD34 further support AML, as these are commonly expressed in this type of leukemia. So putting it all together: pancytopenia with blasts in the peripheral blood, specific myeloid markers, and the patient's age and symptoms all point towards acute myeloid leukemia as the most likely diagnosis. </sub-think 7> 
[<LLM> Question 7]: What diagnostic criteria differentiate AML from other pancytopenia causes?  
[Answer 7]: The presence of ≥20% blasts in bone marrow or peripheral blood confirms AML. This patient's peripheral blast cells with myeloid markers meet diagnostic criteria even without bone marrow biopsy.  
</think> 
<answer>
[Final Content]:  
The patient presents with pancytopenia and constitutional symptoms indicative of bone marrow failure [1,2].  
Peripheral blasts with myeloid markers (myeloperoxidase+, CD33+, CD34+) specifically point to acute myeloid leukemia [3,4,5].  
Age is a key risk factor for AML development [6], and blast percentage meets diagnostic criteria [7].  
So the final answer is Acute myeloid leukemia (AML).
</answer>

Example 3 (Please strictly follow the format of <sub-think number>-</sub-think number> [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
Before generating each [Query], you should do some thinking within <sub-think> </sub-think> to clarify your motivation for generating this [Query].
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] and <sub-think> cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
User: [Description of the patient]: A 29-year-old woman is currently receiving treatment following the birth of her child. She is experiencing some challenges related to her recovery, including feelings of discomfort and systemic symptoms that have arisen after her cesarean delivery. The care team is actively monitoring her condition to ensure her health and well-being during this critical postpartum period.
[symptoms, medical history, and test results]: Fever, chills, heavy feeling in breasts, nausea, abdominal pain, full and tender breasts, mild lower limb swelling, diffuse abdominal tenderness, foul-smelling lochia, marked uterine tenderness.  \nMedical history: Recently delivered a baby via cesarean section due to abruptio placentae at 36 weeks' gestation.  \nVitals: Temperature 39.3\u00b0C (102.7\u00b0F); pulse 101/min; blood pressure 110/70 mm Hg.  \nLaboratory studies: Hemoglobin 11.3 g/dL; leukocyte count 16,300/mm\u00b3; D-dimer 130 ng/mL (normal < 250 ng/mL); serum creatinine 1.2 mg/dL.  \nImaging: Pelvic ultrasonography shows an empty uterus.\n\n
[Question]: What is the most appropriate next step in management?
Assistant:
<think>
<sub-think 1> Okay, let's tackle this case. The question is about the next step in management. First of all, I need to understand the main postpartum symptoms of pregnant women. </sub-think 1>
[<Physician> Question 1]: What are the patient's primary postpartum symptoms?  
[Answer 1]: The patient presents with fever (39.3°C), chills, abdominal pain, foul-smelling lochia, uterine tenderness, and full/tender breasts.  
<sub-think 2> I need to consider postpartum complications with symptoms of fever and uterine tenderness </sub-think 2>
[<LLM> Question 2]: What postpartum complications typically present with fever and uterine tenderness?  
[Answer 2]: Endometritis (uterine infection) is the most common cause of postpartum fever with uterine tenderness, especially after cesarean delivery. Other considerations include mastitis, urinary tract infection, or septic pelvic thrombophlebitis.  
<sub-think 3> To further determine the possibility of endometritis, I need to know what risk factors the patient encountered during delivery that may have led to endometritis.  </sub-think 3>
[<Physician> Question 3]: What delivery-related risk factors does this patient have?  
[Answer 3]: The patient underwent cesarean section for abruptio placentae, which significantly increases the risk of postpartum endometritis compared to vaginal delivery.  
<sub-think 4> To confirm the diagnosis of endometritis, in addition to the fever, I need relevant laboratory test results, such as white blood cell count to prove systemic infection. </sub-think 4>
[<Physician> Question 4]: What laboratory findings support an infectious process?  
[Answer 4]: Elevated leukocyte count (16,300/mm³) and fever confirm systemic inflammation/infection. Normal D-dimer makes thrombotic events less likely.  
<sub-think 5> Retained products of conception may also lead to infection, and a pelvic ultrasound is needed to determine whether there is any product retained in the uterus. </sub-think 5>
[<Physician> Question 5]: Does the pelvic ultrasound reveal any retained material in the uterus?
[Answer 5]: The empty uterus on ultrasound helps rule out retained products of conception as the infection source.  
<sub-think 6> Her cesarean section is a risk factor for endometritis. The lab results show leukocytosis, supporting an infection. The pelvic ultrasound showing an empty uterus rules out retained products of conception, which can cause infection. So endometritis is likely. But what about other possibilities like septic pelvic thrombophlebitis or pyelonephritis? The D-dimer is normal, making thrombosis less likely. No urinary symptoms mentioned, so maybe not pyelo. The key here is to determine the appropriate treatment. Endometritis is typically treated with broad-spectrum antibiotics covering polymicrobial organisms, including anaerobes. Common regimens include clindamycin plus gentamicin, or ampicillin-sulbactam. Since she's postpartum and had a C-section, IV antibiotics are necessary. The question is whether to start antibiotics immediately or do more tests. But given the clinical presentation and lab results, starting empiric antibiotics seems right. Blood cultures might be done, but treatment shouldn't be delayed. So the next step is initiating IV antibiotics like clindamycin and gentamicin. </sub-think 6>
[<LLM> Question 6]: What is the first-line treatment for postpartum endometritis?  
[Answer 6]:Broad-spectrum IV antibiotics covering gram-positive, gram-negative, and anaerobic bacteria are essential. Clindamycin plus gentamicin is the gold standard regimen for polymicrobial coverage in endometritis.  
</think>
<answer>
[Final Content]:  
The patient has classic signs of postpartum endometritis including fever, uterine tenderness, and foul lochia [1].  
Cesarean delivery significantly increases infection risk [3].  
Lab results confirm infectious process with leukocytosis [4].  
Imaging rules out retained products [5].  
First-line treatment requires immediate IV antibiotics with clindamycin/gentamicin combination [6].  
So the final answer is Initiate intravenous clindamycin and gentamicin.
</answer>

Example 4 (Please strictly follow the format of <sub-think number>-</sub-think number> [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
Before generating each [Query], you should do some thinking within <sub-think> </sub-think> to clarify your motivation for generating this [Query].
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] and <sub-think> cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
User: [Description of the patient]: A 4-year-old girl is currently receiving treatment for an illness characterized by gastrointestinal symptoms and a notable change in her overall health. Despite her recent challenges, she is under careful observation and management to address her condition and ensure her recovery.
[symptoms, medical history, and test results]: Diarrhea and vomiting for 5 days; appears pale and irritable; petechiae on trunk and extremities; diffuse abdominal tenderness with hyperactive bowel sounds.  \nMedical history: Vaccinations are up-to-date.  \nLaboratory studies:  \n- Hemoglobin: 8 g/dL  \n- Leukocyte count: 17,000/mm\u00b3  \n- Platelet count: 49,000/mm\u00b3  \n- Serum Creatinine: 1.6 mg/dL  \n- Lactate dehydrogenase: 300 U/L  \n- Coagulation studies: normal.  \n- Peripheral blood smear: shown.  \n\n
[Question]: What is the most likely underlying cause of these findings?
<think>
<sub-think 1> Okay, let's tackle this case. First, I need to understand the patient's specific symptoms, especially those related to the gastrointestinal tract. </sub-think 1>
[<Physician> Question 1]: What are the patient's primary symptoms and their duration?  
[Answer 1]: The patient has experienced diarrhea and vomiting, plus petechiae for 5 days, along with pallor, irritability, petechiae on trunk/extremities, and diffuse abdominal tenderness with hyperactive bowel sounds.  
<sub-think 2> I need to figure out the possible causes. The combination of diarrhea, vomiting, and petechiae makes me think of something like HUS, which is common after gastrointestinal infections, especially E. coli. </sub-think 2>
[<LLM> Question 2]: What conditions cause the combination of diarrhea, vomiting, and petechiae in children?  
[Answer 2]: Hemolytic uremic syndrome (HUS) is the most common cause of this triad in young children, typically following a diarrheal illness caused by Shiga toxin-producing E. coli (STEC).  
<sub-think 3> I need the lab results support HUS, specificall, I need to see if there are any lab results for hemolytic anemia, such as low hemoglobin, low platelets, high leukocytes, etc. </sub-think 3>
[<Physician> Question 3]: Are there laboratory findings supporting hemolytic anemia?  
[Answer 3]: Yes, the hemoglobin is low (8 g/dL), lactate dehydrogenase is elevated (300 U/L), and the peripheral blood smear likely shows schistocytes - all indicative of microangiopathic hemolytic anemia.  The platelet count of 49,000/mm³ reflects consumptive thrombocytopenia from microthrombi formation in small vessels.
<sub-think 4> I need to further observe whether there is kidney injury to support HUS </sub-think 4>
[<Physician> Question 4]: What evidence suggests kidney dysfunction?  
[Answer 4]: The elevated serum creatinine (1.6 mg/dL) indicates acute kidney injury, which is characteristic of HUS progression.  
<sub-think 5> Looking at the lab results: Hemoglobin 8 is low, indicating anemia. Platelets at 49,000 are low, which fits with HUS. Elevated creatinine (1.6 mg/dL in a child) suggests acute kidney injury. High LDH supports hemolysis. The peripheral smear might show schistocytes, which are fragmented red blood cells, a hallmark of HUS. 
Other possibilities? ITP could cause low platelets but not anemia and kidney issues. TTP is possible but less common in children and usually has neurological symptoms. Leukemia could present with cytopenias, but the acute onset and lab findings like elevated LDH and renal involvement make HUS more likely.</sub-think 5>
[<LLM> Question 5]: Based on the above results such as anemia, thrombocytopenia, and renal injury, can we conclude that HUS is the most likely diagnosis?
[Answer 5]: Putting it all together, the most probable diagnosis is HUS, typically post-diarrheal, often from E. coli O157:H7. The triad of anemia, thrombocytopenia, and renal injury fits perfectly.
</think>
<answer>
[Final Content]:  
The patient presents with diarrhea-associated HUS triad: microangiopathic hemolytic anemia [3], thrombocytopenia [3], and acute kidney injury [4].  
Laboratory findings (anemia, elevated LDH, schistocytes on smear) confirm hemolysis [3].  
The clinical progression following gastroenteritis strongly suggests STEC-associated HUS [2].  
So the final answer is Hemolytic uremic syndrome (HUS) secondary to Shiga toxin-producing E. coli infection.
</answer>

Please strictly follow the format of <sub-think number>-</sub-think number> [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in examples, and do not enter any content outside of the format.
Before generating each [Query], you should do some thinking within <sub-think> </sub-think> to clarify your motivation for generating this [Query].
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] and <sub-think> cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.

"""


Prompt_gpt_ask_assistant_o1_preview_with_mark_open_end_add_subthink = """
This is a step-by-step thinking process of a doctor in a clinical consultation, organized in the form of [Query]-[Answer] pairs.
Please add the doctor's thinking before each [Query] to make the logical connection between [Query] smoother and tighter.
This thinking should be marked with <sub-think> </sub-think>.
Please note that you cannot change anything else, you can only add thoughts in <sub-think> to make the logic tighter and smoother!
Please note that you cannot change anything else, you can only add thoughts in <sub-think> to make the logic tighter and smoother!
Please note that you cannot change anything else, you can only add thoughts in <sub-think> to make the logic tighter and smoother!
Please note that you cannot change anything else, you can only add thoughts in <sub-think> to make the logic tighter and smoother!
For example:

Example 1 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
### User:
[Description of the patient]: A 62-year-old woman is currently receiving treatment for a respiratory condition that has contributed to her feelings of fatigue and difficulty breathing, especially with exertion. With a significant history as a nurse and various chronic health concerns, she is actively working with her healthcare team to manage and improve her respiratory health while adjusting to her recent retirement.
[Question]: What is the most likely underlying cause of this patient's symptoms?
[Doctor]:
<think>
[<Physician> Question 1]: What are the patient's primary respiratory symptoms and their duration?  
[Answer 1]: The patient has experienced a productive cough with white phlegm and shortness of breath on exertion (e.g., walking up stairs) for the past 2 years. She also reports fatigue.  
[<Physician> Question 2]: What is the patient's smoking history?  
[Answer 2]: The patient has a 40-year history of smoking 1 pack of cigarettes daily.  
[<Physician> Question 3]: What are the findings on physical examination of the lungs?  
[Answer 3]: The physical examination reveals scattered wheezing and rhonchi throughout both lung fields.  
[<Physician> Question 4]: Are there any signs of heart failure or other systemic issues?  
[Answer 4]: The heart sounds are distant, but there are no murmurs, rubs, or gallops. The patient has hypertension and hyperlipidemia but no overt signs of heart failure.  
[<Physician> Question 5]: Are there any spirometry results or imaging studies available?  
[Answer 5]: No specific spirometry results or imaging studies are mentioned in the provided information.  
[<LLM> Question 6]: What is the most likely diagnosis for a patient with chronic cough, shortness of breath, wheezing, and a significant smoking history?  
[Answer 6]: The most likely diagnosis is chronic obstructive pulmonary disease (COPD), particularly chronic bronchitis given the productive cough.  
</think>
<answer>
[Final Content]:  
The patient presents with chronic respiratory symptoms including a productive cough and shortness of breath on exertion [1].  
Her significant smoking history (40 years, 1 pack/day) is a major risk factor for COPD [2].  
Physical examination findings of wheezing and rhonchi support airway obstruction [3].  
The absence of signs of heart failure or other systemic issues further points to COPD [4].  
So the final answer is Chronic obstructive pulmonary disease (COPD), likely chronic bronchitis.
</answer>

Please note that you cannot change anything else, you can only add thoughts in <sub-think> to make the logic tighter and smoother!
### Assistant:
<think>
<sub-think 1> Okay, let's tackle this case. First, I need to understand the patient's specific respiratory symptoms and their duration. </sub-think 1>
[<Physician> Question 1]: What are the patient's primary respiratory symptoms and their duration?  
[Answer 1]: The patient has experienced a productive cough with white phlegm and shortness of breath on exertion (e.g., walking up stairs) for the past 2 years. She also reports fatigue.  
<sub-think 2> I need to consider the patient's risk factors for chronic respiratory conditions, particularly her smoking history. </sub-think 2>
[<Physician> Question 2]: What is the patient's smoking history?  
[Answer 2]: The patient has a 40-year history of smoking 1 pack of cigarettes daily.  
<sub-think 3> Given the chronic nature of her symptoms and her significant smoking history, I need to consider chronic obstructive pulmonary disease (COPD) as a likely diagnosis. I need to know if there are any physical examination findings that support this. </sub-think 3>
[<Physician> Question 3]: What are the findings on physical examination of the lungs?  
[Answer 3]: The physical examination reveals scattered wheezing and rhonchi throughout both lung fields.  
<sub-think 4> Wheezing and rhonchi are common in COPD, but I need to rule out other conditions like asthma or heart failure. I need to know if there are any signs of heart failure or other systemic issues. </sub-think 4>
[<Physician> Question 4]: Are there any signs of heart failure or other systemic issues?  
[Answer 4]: The heart sounds are distant, but there are no murmurs, rubs, or gallops. The patient has hypertension and hyperlipidemia but no overt signs of heart failure.  
<sub-think 5> The patient's symptoms, smoking history, and physical examination findings strongly suggest COPD. However, I need to confirm this with additional information, such as spirometry results or imaging. </sub-think 5>
[<Physician> Question 5]: Are there any spirometry results or imaging studies available?  
[Answer 5]: No specific spirometry results or imaging studies are mentioned in the provided information.  
<sub-think 6> Despite the lack of spirometry results, the patient's chronic symptoms, smoking history, and physical examination findings are highly suggestive of COPD. The absence of signs of heart failure or other systemic issues further supports this diagnosis. </sub-think 6>
[<LLM> Question 6]: What is the most likely diagnosis for a patient with chronic cough, shortness of breath, wheezing, and a significant smoking history?  
[Answer 6]: The most likely diagnosis is chronic obstructive pulmonary disease (COPD), particularly chronic bronchitis given the productive cough.  
</think>
<answer>
[Final Content]:  
The patient presents with chronic respiratory symptoms including a productive cough and shortness of breath on exertion [1].  
Her significant smoking history (40 years, 1 pack/day) is a major risk factor for COPD [2].  
Physical examination findings of wheezing and rhonchi support airway obstruction [3].  
The absence of signs of heart failure or other systemic issues further points to COPD [4].  
So the final answer is Chronic obstructive pulmonary disease (COPD), likely chronic bronchitis.
</answer>

Example 2 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
### User:
[Description of the patient]: A 63-year-old man is currently under medical care due to a condition that has led to increasing fatigue and challenges in daily living activities. He has a background of managing high blood pressure and cholesterol and is following a treatment plan aimed at addressing his recent health concerns and improving his overall quality of life
[Question]: What is the most likely diagnosis?
[Doctor]:
<think> 
[<Physician> Question 1]: What are the patient's primary symptoms and duration of illness?  
[Answer 1]: The patient reports 3 months of increasing generalized fatigue, difficulty performing daily activities, and unintentional weight loss of 2.5 kg over the past month. Physical examination reveals pale conjunctivae.  
[<Physician> Question 2]: Are there any laboratory results that suggest the patient may be anemic?
[Answer 2]: The labs confirm anemia with a hematocrit of 27.3%, which is quite low. Additionally, he has leukopenia (low white cells) and thrombocytopenia (low platelets).
[<LLM> Question 3]: What conditions typically present with pancytopenia (low hematocrit, leukocytes, and platelets) in older adults?  
[Answer 3]: Pancytopenia in this age group could indicate bone marrow failure syndromes, myelodysplastic syndromes (MDS), acute leukemias, or metastatic cancer infiltration. The presence of blast cells in peripheral blood narrows the possibilities.  
[<Physician> Question 4]: What specific findings were noted on the peripheral blood smear?  
[Answer 4]: The peripheral blood smear shows numerous blast cells that stain positive for myeloperoxidase, CD33, and CD34 – markers characteristic of myeloid lineage cells.  
[<LLM> Question 5]: How do these cellular markers (myeloperoxidase+, CD33+, CD34+) help differentiate types of leukemia?  
[Answer 5]: Myeloperoxidase positivity indicates myeloid differentiation. CD33 is a myeloid-associated antigen, while CD34 is a stem cell marker. This combination strongly suggests acute myeloid leukemia (AML) rather than lymphoid leukemia.  
[<Physician> Question 6]: Does the patient have risk factors for hematologic malignancies?  
[Answer 6]: While the patient has hypertension and hyperlipidemia, these are not direct risk factors. His age (63 years) is a significant risk factor for AML development.  
[<LLM> Question 7]: What diagnostic criteria differentiate AML from other pancytopenia causes?  
[Answer 7]: The presence of ≥20% blasts in bone marrow or peripheral blood confirms AML. This patient's peripheral blast cells with myeloid markers meet diagnostic criteria even without bone marrow biopsy.  
</think> 
<answer>
[Final Content]:  
The patient presents with pancytopenia and constitutional symptoms indicative of bone marrow failure [1,2].  
Peripheral blasts with myeloid markers (myeloperoxidase+, CD33+, CD34+) specifically point to acute myeloid leukemia [3,4,5].  
Age is a key risk factor for AML development [6], and blast percentage meets diagnostic criteria [7].  
So the final answer is Acute myeloid leukemia (AML).
</answer>

Please note that you cannot change anything else, you can only add thoughts in <sub-think> to make the logic tighter and smoother!
### Assistant:
<think> 
<sub-think 1> Okay, let's tackle this case.  First of all, I need to know the patient's specific main symptoms and duration。 </sub-think 1>
[<Physician> Question 1]: What are the patient's primary symptoms and duration of illness?  
[Answer 1]: The patient reports 3 months of increasing generalized fatigue, difficulty performing daily activities, and unintentional weight loss of 2.5 kg over the past month. Physical examination reveals pale conjunctivae.  
<sub-think 2>  I need to figure out the most likely diagnosis. Let's start by breaking down the symptoms and lab results. The key symptoms here are fatigue, weight loss, and pale conjunctivae, which suggest anemia. I need lab tests to confirm the patient's anemia. </sub-think 2>
[<Physician> Question 2]: Are there any laboratory results that suggest the patient may be anemic?
[Answer 2]: The labs confirm anemia with a hematocrit of 27.3%, which is quite low. Additionally, he has leukopenia (low white cells) and thrombocytopenia (low platelets).
<sub-think 3> The patient is an elderly person, and the lab results show that the patient's red blood cell, white blood cell, and platelet triad is low. I need to determine what disease this indicates. </sub-think 3>
[<LLM> Question 3]: What conditions typically present with pancytopenia (low hematocrit, leukocytes, and platelets) in older adults?  
[Answer 3]: Pancytopenia in this age group could indicate bone marrow failure syndromes, myelodysplastic syndromes (MDS), acute leukemias, or metastatic cancer infiltration. The presence of blast cells in peripheral blood narrows the possibilities.  
<sub-think 4> To narrow it down, I need to look at the patient's peripheral blood smear. </sub-think 4>
[<Physician> Question 4]: What specific findings were noted on the peripheral blood smear?  
[Answer 4]: The peripheral blood smear shows numerous blast cells that stain positive for myeloperoxidase, CD33, and CD34 – markers characteristic of myeloid lineage cells.  
<sub-think 5> The presence of blast cells is critical. Blast cells are immature cells, and their presence in the blood is abnormal. The positive staining for myeloperoxidase, CD33, and CD34 are markers that help identify the type of leukemia. Myeloperoxidase is typically seen in myeloid cells, so this suggests a myeloid lineage. CD33 and CD34 are markers often associated with acute myeloid leukemia (AML). </sub-think 5>
[<LLM> Question 5]: How do these cellular markers (myeloperoxidase+, CD33+, CD34+) help differentiate types of leukemia?  
[Answer 5]: Myeloperoxidase positivity indicates myeloid differentiation. CD33 is a myeloid-associated antigen, while CD34 is a stem cell marker. This combination strongly suggests acute myeloid leukemia (AML) rather than lymphoid leukemia.  
<sub-think 6> To further confirm the diagnosis, I need to know the patient's age, medical history, smoking and drinking history, and whether there are high-risk factors for acute myeloid leukemia. </sub-think 6> 
[<Physician> Question 6]: Does the patient have risk factors for hematologic malignancies?  
[Answer 6]: While the patient has hypertension and hyperlipidemia, these are not direct risk factors. His age (63 years) is a significant risk factor for AML development.  
<sub-think 7> Differential diagnoses might include other types of leukemia or myelodysplastic syndromes (MDS). However, the presence of blast cells exceeding 20% in the bone marrow (implied by their presence in peripheral blood) is a key criterion for AML rather than MDS. The markers CD33 and CD34 further support AML, as these are commonly expressed in this type of leukemia. So putting it all together: pancytopenia with blasts in the peripheral blood, specific myeloid markers, and the patient's age and symptoms all point towards acute myeloid leukemia as the most likely diagnosis. </sub-think 7> 
[<LLM> Question 7]: What diagnostic criteria differentiate AML from other pancytopenia causes?  
[Answer 7]: The presence of ≥20% blasts in bone marrow or peripheral blood confirms AML. This patient's peripheral blast cells with myeloid markers meet diagnostic criteria even without bone marrow biopsy.  
</think> 
<answer>
[Final Content]:  
The patient presents with pancytopenia and constitutional symptoms indicative of bone marrow failure [1,2].  
Peripheral blasts with myeloid markers (myeloperoxidase+, CD33+, CD34+) specifically point to acute myeloid leukemia [3,4,5].  
Age is a key risk factor for AML development [6], and blast percentage meets diagnostic criteria [7].  
So the final answer is Acute myeloid leukemia (AML).
</answer>

Example 3 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
### User:
[Description of the patient]: A 29-year-old woman is currently receiving treatment following the birth of her child. She is experiencing some challenges related to her recovery, including feelings of discomfort and systemic symptoms that have arisen after her cesarean delivery. The care team is actively monitoring her condition to ensure her health and well-being during this critical postpartum period.
[Question]: What is the most appropriate next step in management?
Doctor]:
<think>
[<Physician> Question 1]: What are the patient's primary postpartum symptoms?  
[Answer 1]: The patient presents with fever (39.3°C), chills, abdominal pain, foul-smelling lochia, uterine tenderness, and full/tender breasts.  
[<LLM> Question 2]: What postpartum complications typically present with fever and uterine tenderness?  
[Answer 2]: Endometritis (uterine infection) is the most common cause of postpartum fever with uterine tenderness, especially after cesarean delivery. Other considerations include mastitis, urinary tract infection, or septic pelvic thrombophlebitis.  
[<Physician> Question 3]: What delivery-related risk factors does this patient have?  
[Answer 3]: The patient underwent cesarean section for abruptio placentae, which significantly increases the risk of postpartum endometritis compared to vaginal delivery.  
[<Physician> Question 4]: What laboratory findings support an infectious process?  
[Answer 4]: Elevated leukocyte count (16,300/mm³) and fever confirm systemic inflammation/infection. Normal D-dimer makes thrombotic events less likely.  
[<Physician> Question 5]: Does the pelvic ultrasound reveal any retained material in the uterus?
[Answer 5]: The empty uterus on ultrasound helps rule out retained products of conception as the infection source.  
[<LLM> Question 6]: What is the first-line treatment for postpartum endometritis?  
[Answer 6]:Broad-spectrum IV antibiotics covering gram-positive, gram-negative, and anaerobic bacteria are essential. Clindamycin plus gentamicin is the gold standard regimen for polymicrobial coverage in endometritis.  
</think>
<answer>
[Final Content]:  
The patient has classic signs of postpartum endometritis including fever, uterine tenderness, and foul lochia [1].  
Cesarean delivery significantly increases infection risk [3].  
Lab results confirm infectious process with leukocytosis [4].  
Imaging rules out retained products [5].  
First-line treatment requires immediate IV antibiotics with clindamycin/gentamicin combination [6].  
So the final answer is Initiate intravenous clindamycin and gentamicin.
</answer>

Please note that you cannot change anything else, you can only add thoughts in <sub-think> to make the logic tighter and smoother!
### Assistant:
<think>
<sub-think 1> Okay, let's tackle this case. The question is about the next step in management. First of all, I need to understand the main postpartum symptoms of pregnant women. </sub-think 1>
[<Physician> Question 1]: What are the patient's primary postpartum symptoms?  
[Answer 1]: The patient presents with fever (39.3°C), chills, abdominal pain, foul-smelling lochia, uterine tenderness, and full/tender breasts.  
<sub-think 2> I need to consider postpartum complications with symptoms of fever and uterine tenderness </sub-think 2>
[<LLM> Question 2]: What postpartum complications typically present with fever and uterine tenderness?  
[Answer 2]: Endometritis (uterine infection) is the most common cause of postpartum fever with uterine tenderness, especially after cesarean delivery. Other considerations include mastitis, urinary tract infection, or septic pelvic thrombophlebitis.  
<sub-think 3> To further determine the possibility of endometritis, I need to know what risk factors the patient encountered during delivery that may have led to endometritis.  </sub-think 3>
[<Physician> Question 3]: What delivery-related risk factors does this patient have?  
[Answer 3]: The patient underwent cesarean section for abruptio placentae, which significantly increases the risk of postpartum endometritis compared to vaginal delivery.  
<sub-think 4> To confirm the diagnosis of endometritis, in addition to the fever, I need relevant laboratory test results, such as white blood cell count to prove systemic infection. </sub-think 4>
[<Physician> Question 4]: What laboratory findings support an infectious process?  
[Answer 4]: Elevated leukocyte count (16,300/mm³) and fever confirm systemic inflammation/infection. Normal D-dimer makes thrombotic events less likely.  
<sub-think 5> Retained products of conception may also lead to infection, and a pelvic ultrasound is needed to determine whether there is any product retained in the uterus. </sub-think 5>
[<Physician> Question 5]: Does the pelvic ultrasound reveal any retained material in the uterus?
[Answer 5]: The empty uterus on ultrasound helps rule out retained products of conception as the infection source.  
<sub-think 6> Her cesarean section is a risk factor for endometritis. The lab results show leukocytosis, supporting an infection. The pelvic ultrasound showing an empty uterus rules out retained products of conception, which can cause infection. So endometritis is likely. But what about other possibilities like septic pelvic thrombophlebitis or pyelonephritis? The D-dimer is normal, making thrombosis less likely. No urinary symptoms mentioned, so maybe not pyelo. The key here is to determine the appropriate treatment. Endometritis is typically treated with broad-spectrum antibiotics covering polymicrobial organisms, including anaerobes. Common regimens include clindamycin plus gentamicin, or ampicillin-sulbactam. Since she's postpartum and had a C-section, IV antibiotics are necessary. The question is whether to start antibiotics immediately or do more tests. But given the clinical presentation and lab results, starting empiric antibiotics seems right. Blood cultures might be done, but treatment shouldn't be delayed. So the next step is initiating IV antibiotics like clindamycin and gentamicin. </sub-think 6>
[<LLM> Question 6]: What is the first-line treatment for postpartum endometritis?  
[Answer 6]:Broad-spectrum IV antibiotics covering gram-positive, gram-negative, and anaerobic bacteria are essential. Clindamycin plus gentamicin is the gold standard regimen for polymicrobial coverage in endometritis.  
</think>
<answer>
[Final Content]:  
The patient has classic signs of postpartum endometritis including fever, uterine tenderness, and foul lochia [1].  
Cesarean delivery significantly increases infection risk [3].  
Lab results confirm infectious process with leukocytosis [4].  
Imaging rules out retained products [5].  
First-line treatment requires immediate IV antibiotics with clindamycin/gentamicin combination [6].  
So the final answer is Initiate intravenous clindamycin and gentamicin.
</answer>

Example 4 (Please strictly follow the format of [Query number]-[Answer number] (started with [xxx Query 1]), [Final Content] in the following example, and do not enter any content outside of the format.):
### User:
[Description of the patient]: A 4-year-old girl is currently receiving treatment for an illness characterized by gastrointestinal symptoms and a notable change in her overall health. Despite her recent challenges, she is under careful observation and management to address her condition and ensure her recovery.
[Question]: What is the most likely underlying cause of these findings?
[Doctor]:
<think>
[<Physician> Question 1]: What are the patient's primary symptoms and their duration?  
[Answer 1]: The patient has experienced diarrhea and vomiting, plus petechiae for 5 days, along with pallor, irritability, petechiae on trunk/extremities, and diffuse abdominal tenderness with hyperactive bowel sounds.  
[<LLM> Question 2]: What conditions cause the combination of diarrhea, vomiting, and petechiae in children?  
[Answer 2]: Hemolytic uremic syndrome (HUS) is the most common cause of this triad in young children, typically following a diarrheal illness caused by Shiga toxin-producing E. coli (STEC).  
[<Physician> Question 3]: Are there laboratory findings supporting hemolytic anemia?  
[Answer 3]: Yes, the hemoglobin is low (8 g/dL), lactate dehydrogenase is elevated (300 U/L), and the peripheral blood smear likely shows schistocytes - all indicative of microangiopathic hemolytic anemia.  The platelet count of 49,000/mm³ reflects consumptive thrombocytopenia from microthrombi formation in small vessels.
[<Physician> Question 4]: What evidence suggests kidney dysfunction?  
[Answer 4]: The elevated serum creatinine (1.6 mg/dL) indicates acute kidney injury, which is characteristic of HUS progression.  
[<LLM> Question 5]: Based on the above results such as anemia, thrombocytopenia, and renal injury, can we conclude that HUS is the most likely diagnosis?
[Answer 5]: Putting it all together, the most probable diagnosis is HUS, typically post-diarrheal, often from E. coli O157:H7. The triad of anemia, thrombocytopenia, and renal injury fits perfectly.
</think>
<answer>
[Final Content]:  
The patient presents with diarrhea-associated HUS triad: microangiopathic hemolytic anemia [3], thrombocytopenia [3], and acute kidney injury [4].  
Laboratory findings (anemia, elevated LDH, schistocytes on smear) confirm hemolysis [3].  
The clinical progression following gastroenteritis strongly suggests STEC-associated HUS [2].  
So the final answer is Hemolytic uremic syndrome (HUS) secondary to Shiga toxin-producing E. coli infection.
</answer>

Please note that you cannot change anything else, you can only add thoughts in <sub-think> to make the logic tighter and smoother!
### Assistant:
<think>
<sub-think 1> Okay, let's tackle this case. First, I need to understand the patient's specific symptoms, especially those related to the gastrointestinal tract. </sub-think 1>
[<Physician> Question 1]: What are the patient's primary symptoms and their duration?  
[Answer 1]: The patient has experienced diarrhea and vomiting, plus petechiae for 5 days, along with pallor, irritability, petechiae on trunk/extremities, and diffuse abdominal tenderness with hyperactive bowel sounds.  
<sub-think 2> I need to figure out the possible causes. The combination of diarrhea, vomiting, and petechiae makes me think of something like HUS, which is common after gastrointestinal infections, especially E. coli. </sub-think 2>
[<LLM> Question 2]: What conditions cause the combination of diarrhea, vomiting, and petechiae in children?  
[Answer 2]: Hemolytic uremic syndrome (HUS) is the most common cause of this triad in young children, typically following a diarrheal illness caused by Shiga toxin-producing E. coli (STEC).  
<sub-think 3> I need the lab results support HUS, specificall, I need to see if there are any lab results for hemolytic anemia, such as low hemoglobin, low platelets, high leukocytes, etc. </sub-think 3>
[<Physician> Question 3]: Are there laboratory findings supporting hemolytic anemia?  
[Answer 3]: Yes, the hemoglobin is low (8 g/dL), lactate dehydrogenase is elevated (300 U/L), and the peripheral blood smear likely shows schistocytes - all indicative of microangiopathic hemolytic anemia.  The platelet count of 49,000/mm³ reflects consumptive thrombocytopenia from microthrombi formation in small vessels.
<sub-think 4> I need to further observe whether there is kidney injury to support HUS </sub-think 4>
[<Physician> Question 4]: What evidence suggests kidney dysfunction?  
[Answer 4]: The elevated serum creatinine (1.6 mg/dL) indicates acute kidney injury, which is characteristic of HUS progression.  
<sub-think 5> Looking at the lab results: Hemoglobin 8 is low, indicating anemia. Platelets at 49,000 are low, which fits with HUS. Elevated creatinine (1.6 mg/dL in a child) suggests acute kidney injury. High LDH supports hemolysis. The peripheral smear might show schistocytes, which are fragmented red blood cells, a hallmark of HUS. 
Other possibilities? ITP could cause low platelets but not anemia and kidney issues. TTP is possible but less common in children and usually has neurological symptoms. Leukemia could present with cytopenias, but the acute onset and lab findings like elevated LDH and renal involvement make HUS more likely.</sub-think 5>
[<LLM> Question 5]: Based on the above results such as anemia, thrombocytopenia, and renal injury, can we conclude that HUS is the most likely diagnosis?
[Answer 5]: Putting it all together, the most probable diagnosis is HUS, typically post-diarrheal, often from E. coli O157:H7. The triad of anemia, thrombocytopenia, and renal injury fits perfectly.
</think>
<answer>
[Final Content]:  
The patient presents with diarrhea-associated HUS triad: microangiopathic hemolytic anemia [3], thrombocytopenia [3], and acute kidney injury [4].  
Laboratory findings (anemia, elevated LDH, schistocytes on smear) confirm hemolysis [3].  
The clinical progression following gastroenteritis strongly suggests STEC-associated HUS [2].  
So the final answer is Hemolytic uremic syndrome (HUS) secondary to Shiga toxin-producing E. coli infection.
</answer>"""

Prompt_gpt_ask_assistant_v4_with_mark = """
You are an experienced medical professional. Your current role is a doctor who is examining a patient to answer the [Question]. The patient's description is in [Description of the patient].
You should pretend not to know the content in [symptoms, medical history, and test results] and get them through reasoning step by step in the chain to solve the [Question].
You should reason about the [Question] step by step and get content in [symptoms, medical history, and test results] during the reasoning process. Each question to access [symptoms, medical history, and test results] should arise naturally as part of the logical flow, ensuring that it aligns with the clinical reasoning process.
For each node of the chain, you should generate a query, starting with [Query number]. You must give the answer for [Query number], starting with [Answer number].
Each node of the chain can be a query and answer to the content in [symptoms, medical history, and test results], or a query and answer to related medical knowledge.
You should mark the queries that ask for the content in [symptoms, medical history, and test results] with [<Physician> Question].
You should mark the queries that ask for the related objective medical knowledge with [<LLM> Question].
There should be strict logical connections between nodes, such as relevant medical knowledge or your medical experience
Emphasize again that you are now simulating a doctor who is consulting a patient. You do not know all the information in [symptoms, medical history, and test results], and you must obtain them through step-by-step reasoning in the form of self-questioning and self-answering in the chain. Therefore, all [Query] cannot contain any [symptoms, medical history, and test results] information that is unknown in the current reasoning step.
If the reasoning is finished, you can generate the final answer for the [Question] by referring to the [Query]-[Answer] pairs, starting with [Final Content] and marking the number for each [Answer].
You must give the final answer by "So the final answer is ".
[Description of the patient]: 
[symptoms, medical history, and test results]: 
[Question]:

For example:
### User: [Description of the patient]: A 62-year-old woman is currently under regular medical supervision to address her heart health and related concerns. She experiences occasional episodes that affect her overall comfort and is actively participating in her treatment plan to enhance her quality of life and manage her heart condition effectively. 
[symptoms, medical history, and test results]:  \nSymptoms: Lightheadedness and palpitations occurring episodically.  \nMedical history: Myocardial infarction 6 months ago; NYHA class II chronic heart failure; diagnosed with grade I arterial hypertension 4 years ago.  \nMedications: Aspirin 81 mg, atorvastatin 10 mg, enalapril 10 mg, and metoprolol 200 mg daily.  \nVitals: Blood pressure 135/90 mm Hg; heart rate 125/min; respiratory rate 14/min; temperature 36.5\u00b0C (97.7\u00b0F).  \nCardiopulmonary examination: Irregular heart rhythm and decreased S1 intensity.  \nEchocardiography: Left ventricular ejection fraction of 39%.
[Question]: Which of the following drugs is the best choice for rate control in this patient? A: Atenolol B: Verapamil C: Diltiazem D: Propafenone E: Digoxin
### Assistant: [<Physician> Question 1]: What are the patient's initial symptoms related to heart health?
[Answer 1]: The patient has some lightheadedness
[<Physician> Question 2]: Whether the patient has palpitations?
[Answer 2]: Yes, the patient has palpitations recently.
[<LLM> Question 3]: What condition could explain the patient's symptoms of lightheadedness and palpitations?
[Answer 3]: Lightheadedness and palpitations could be caused by arrhythmias, such as atrial fibrillation (AF), or other cardiovascular issues like heart failure exacerbation or ischemia. Let’s confirm if the patient has signs of arrhythmia.
[<Physician> Question 4]: What is the patient’s heart rate and rhythm?
[Answer 4]: The patient’s heart rate is 125 bpm, and her rhythm is irregular. This supports a diagnosis of atrial fibrillation (AF) causing rapid ventricular response. Rate control is a priority in managing this condition.
[<Physician> Question 5]: Does the patient have underlying cardiac conditions that influence treatment decisions?
[Answer 5]: Yes, the patient has a history of myocardial infarction 6 months ago, NYHA class II chronic heart failure with reduced ejection fraction (HFrEF, EF 39%), and hypertension. These conditions impact the choice of medications for rate control.
[<Physician> Question 6]: Are there contraindications to using certain rate control medications in this patient?
[Answer 6]: Non-dihydropyridine calcium channel blockers like verapamil and diltiazem are contraindicated in HFrEF due to their negative inotropic effects, which can worsen heart failure. Propafenone, a rhythm control drug, is also unsuitable due to proarrhythmic risks in structural heart disease.
[<Physician> Question 7]: What medications is the patient currently taking, and do they address rate control?
[Answer 7]: The patient is on metoprolol 200 mg daily, which is a beta-blocker commonly used for rate control in AF and heart failure. However, her heart rate of 125 bpm suggests suboptimal rate control, indicating the need for an additional or alternative therapy.
[<LLM> Question 8]: Why might digoxin be a good option in this patient?
[Answer 8]: Digoxin slows the ventricular rate in AF by enhancing vagal tone without adversely affecting cardiac output, making it particularly suitable for patients with HFrEF. It can be used as adjunctive therapy to improve rate control in this patient.
[Final Content]:
The patient has symptoms of dizziness and palpitations. [1,2]
The patient has atrial fibrillation with rapid ventricular response (heart rate 125 bpm) [4].
She has underlying HFrEF and a history of myocardial infarction, influencing the choice of rate control medications [5].
Non-dihydropyridine calcium channel blockers and propafenone are contraindicated in this patient [6].
Atenolol is less effective in heart failure compared to her current beta-blocker (metoprolol) [7].
Digoxin is a safe and effective option for rate control in AF with HFrEF [8].
So the final answer is Digoxin.

### User: [Description of the patient]: A 46-year-old woman is currently undergoing treatment for a condition that has significantly affected her vision and overall well-being. She has been experiencing various symptoms that have emerged over the past few months, and she is in the process of working with her healthcare team to address these challenges while also managing some recent positive changes in her lifestyle
[symptoms, medical history, and test results]: Symptoms: 2-week history of diplopia; ocular pain when reading; 3-month history of amenorrhea, hot flashes, and increased sweating; fine resting tremor of the hands.  \nMedical history: Overweight all her adult life; lost 6.8-kg (15-lb) in the past 2 months.  \nVital signs: Pulse 110/min; blood pressure 148/98 mm Hg.  \nPhysical examination: Moist palms; nontender, enlarged thyroid gland; ophthalmologic findings of globe prominence, bilateral lid retraction, conjunctival injection, and inability to converge the eyes; pain-free extraocular muscle movement; visual acuity 20/20 bilaterally; deep tendon reflexes 3+ with shortened relaxation phase.
[Question]: Which of the following is the most likely cause of this patient's ocular complaints? A: Granulomatous inflammation of the cavernous sinus B: Abnormal communication between the cavernous sinus and the internal carotid artery C: Glycosaminoglycan accumulation in the orbit D: Bacterial infection of the orbital contents E: Sympathetic hyperactivity of levator palpebrae superioris
### Assistant: [<Physician> Question 1]: What are the patient's initial symptoms related to her vision and well-being?
[Answer 1]: The patient reports a 2-week history of diplopia (double vision) and ocular pain when reading.
[<LLM> Question 2]: What disease may cause binocular double vision and eye pain?
[Answer 2]:  Diplopia and ocular discomfort can be caused by various conditions, including thyroid eye disease (Graves' ophthalmopathy), cranial nerve palsies, and other orbital pathologies. These disorders can cause double vision and eye discomfort. They may also be accompanied by systemic symptoms such as hot flashes and excessive sweating.
[<Physician> Question 3]: Does the patient has systemic symptoms, such as hot flashes, excessive sweating, menstrual disorders, etc.? 
[Answer 3]: Yes, the patient reports the systemic symptoms like amenorrhea, hot flashes, and increased sweating.
[<Physician> Question 4]:  Given her systemic symptoms, it may be worth investigating if thyroid dysfunction is involved. Is there any evidence of thyroid dysfunction in the patient's clinical presentation?
[Answer 4]: Yes, the patient has an enlarged, nontender thyroid gland and associated symptoms indicating hyperthyroidism, such as increased sweating and weight loss, which is often seen in Graves’ disease.
[<Physician> Question 5]: What specific findings in this patient suggest the diagnosis of Graves' disease?
[Answer 5]: The patient exhibits exophthalmos (globe prominence), bilateral lid retraction, and an inability to converge her eyes, all of which are indicative of thyroid-associated ophthalmopathy, commonly associated with Graves' disease.
[<LLM> Question 6]: What role do glycosaminoglycans play in the ocular manifestations associated with Graves' disease?
[Answer 6]: Glycosaminoglycans, especially hyaluronic acid, accumulate in the orbit due to autoimmune processes in Graves’ disease, leading to edema and expansion of extraocular muscles, which can result in diplopia and other ocular symptoms.
[<LLM> Question 7]: Given the findings, what is the most likely underlying cause of this patient's ocular complaints?
[Answer 7]: The ocular complaints primarily stem from the accumulation of glycosaminoglycans in the orbit as a result of Graves' disease, which affects the extraocular muscles and the surrounding tissues.
[Final Content]: 
The patient reports diplopia and ocular pain, signifying possible ocular pathology [1,3]. 
She has symptoms consistent with hyperthyroidism and Graves' disease, including globe prominence and other ocular signs [5]. 
Glycosaminoglycan accumulation typically occurs in the context of Graves' disease, leading to the associated ocular manifestations such as diplopia [6,7].
So the final answer is Glycosaminoglycan accumulation in the orbit.

[<Physician> Question 1]: What are the patient's initial symptoms related to her daily life and functionality?
[Answer 1]: The patient has a 1-month history of double vision, difficulty climbing stairs, and weakness in brushing her hair.  
[<LLM> Question 2]: What conditions could cause fluctuating muscle weakness and ocular symptoms?  
[Answer 2]: Conditions such as myasthenia gravis, polymyositis, and multiple sclerosis can cause fluctuating muscle weakness and ocular symptoms like double vision.  
[<Physician> Question 3]: Does the patient's weakness worsen with activity and improve with rest?  
[Answer 3]: Yes, the patient's symptoms worsen with exercise and improve with rest, which is characteristic of myasthenia gravis.  
[<Physician> Question 4]: Are there any specific physical examination findings that support a diagnosis?  
[Answer 4]: Yes, the physical examination shows drooping of the right upper eyelid and diminished motor strength in the upper extremities, which are consistent with myasthenia gravis.  
[<LLM> Question 5]: What is the pathophysiology behind myasthenia gravis? 
[Answer 5]: Myasthenia gravis is an autoimmune disorder where antibodies block or destroy nicotinic acetylcholine receptors at the neuromuscular junction, leading to muscle weakness that worsens with activity.  
[Final Content]:  
The patient has symptoms of double vision and fluctuating muscle weakness that worsens with activity and improves with rest [1,3].  
Physical examination reveals drooping of the right upper eyelid and diminished motor strength in the upper extremities, supporting a diagnosis of myasthenia gravis [4].  
The pathophysiology of myasthenia gravis explains the fluctuating nature of her symptoms [5].  
So the final answer is Myasthenia gravis."
"""